| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP hydrolysis activity | KIF21B SRCAP IFIH1 ABCD3 NAV3 DHX35 KIF5A DDX24 DYNC1H1 KIF22 DHX58 TCP1 NSF MYO18A MORC2 CHTF18 ATP2B2 ATP2B4 | 5.24e-06 | 441 | 235 | 18 | GO:0016887 |
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF21B MYO1C SRCAP IFIH1 ABCD3 NAV3 DHX35 KIF5A DDX24 DYNC1H1 KIF22 DHX58 TCP1 NSF MYO18A MORC2 CHTF18 MYH15 ATP2B2 ATP2B4 | 4.19e-05 | 614 | 235 | 20 | GO:0140657 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | KIF21B LSG1 SRCAP IFIH1 ABCD3 GNL2 NAV3 DHX35 KIF5A DDX24 DYNC1H1 KIF22 DHX58 TCP1 NSF MYO18A MORC2 CHTF18 RND2 ATP2B2 ATP2B4 | 3.48e-04 | 775 | 235 | 21 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | KIF21B LSG1 SRCAP IFIH1 ABCD3 GNL2 NAV3 DHX35 KIF5A DDX24 DYNC1H1 KIF22 DHX58 TCP1 NSF DUT MYO18A MORC2 CHTF18 RND2 ATP2B2 ATP2B4 | 3.94e-04 | 839 | 235 | 22 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | KIF21B LSG1 SRCAP IFIH1 ABCD3 GNL2 NAV3 DHX35 KIF5A DDX24 DYNC1H1 KIF22 DHX58 TCP1 NSF DUT MYO18A MORC2 CHTF18 RND2 ATP2B2 ATP2B4 | 4.01e-04 | 840 | 235 | 22 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | KIF21B LSG1 SRCAP IFIH1 ABCD3 GNL2 NAV3 DHX35 KIF5A DDX24 DYNC1H1 KIF22 DHX58 TCP1 NSF DUT MYO18A MORC2 CHTF18 RND2 ATP2B2 ATP2B4 | 4.01e-04 | 840 | 235 | 22 | GO:0016818 |
| GeneOntologyMolecularFunction | 5-methylcytosine dioxygenase activity | 4.11e-04 | 3 | 235 | 2 | GO:0070579 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 4.28e-04 | 151 | 235 | 8 | GO:0015085 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 4.98e-04 | 118 | 235 | 7 | GO:0003774 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | TANC2 BOC PRTG TENM2 COBL KIF5A PLXNA2 NOTCH2 SYNE1 OBSL1 LAMA5 LAMB3 EDNRA PLEKHG4B BCL11B TIAM1 SIPA1L1 TET1 DOCK7 PLXNA4 ROBO1 RND2 SCRIB CTNND2 ATP2B2 EPHA8 | 4.29e-07 | 748 | 234 | 26 | GO:0048667 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | TANC2 BOC PRTG TENM2 COBL KIF5A PLXNA2 NOTCH2 SYNE1 OBSL1 LAMA5 LAMB3 EDNRA PLEKHG4B BCL11B TIAM1 SIPA1L1 TET1 DOCK7 PLXNA4 ROBO1 RND2 CTNND2 EPHA8 | 1.55e-05 | 802 | 234 | 24 | GO:0048812 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | TANC2 BOC PRTG TENM2 COBL KIF5A PLXNA2 NOTCH2 SYNE1 OBSL1 LAMA5 LAMB3 EDNRA PLEKHG4B BCL11B TIAM1 SIPA1L1 TET1 DOCK7 PLXNA4 ROBO1 RND2 CTNND2 EPHA8 | 2.18e-05 | 819 | 234 | 24 | GO:0120039 |
| GeneOntologyBiologicalProcess | axon guidance | BOC PRTG TENM2 KIF5A NOTCH2 LAMA5 LAMB3 EDNRA PLEKHG4B BCL11B PLXNA4 ROBO1 EPHA8 | 2.43e-05 | 285 | 234 | 13 | GO:0007411 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | TANC2 BOC PRTG TENM2 COBL KIF5A PLXNA2 NOTCH2 SYNE1 OBSL1 LAMA5 LAMB3 EDNRA PLEKHG4B BCL11B TIAM1 SIPA1L1 TET1 DOCK7 PLXNA4 ROBO1 RND2 CTNND2 EPHA8 | 2.50e-05 | 826 | 234 | 24 | GO:0048858 |
| GeneOntologyBiologicalProcess | neuron projection guidance | BOC PRTG TENM2 KIF5A NOTCH2 LAMA5 LAMB3 EDNRA PLEKHG4B BCL11B PLXNA4 ROBO1 EPHA8 | 2.52e-05 | 286 | 234 | 13 | GO:0097485 |
| GeneOntologyBiologicalProcess | axonogenesis | BOC PRTG TENM2 COBL KIF5A PLXNA2 NOTCH2 LAMA5 LAMB3 EDNRA PLEKHG4B BCL11B TIAM1 SIPA1L1 DOCK7 PLXNA4 ROBO1 RND2 EPHA8 | 2.68e-05 | 566 | 234 | 19 | GO:0007409 |
| GeneOntologyBiologicalProcess | activation of GTPase activity | 3.46e-05 | 109 | 234 | 8 | GO:0090630 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | TANC2 BOC PRTG CDC42EP4 TENM2 COBL KIF5A PLXNA2 NOTCH2 ARAP1 SYNE1 OBSL1 LAMA5 LAMB3 FRYL EDNRA WDR19 PLEKHG4B BCL11B TIAM1 SIPA1L1 TET1 DOCK7 PLXNA4 ROBO1 RND2 SCRIB CTNND2 ATP2B2 EPHA8 | 3.72e-05 | 1194 | 234 | 30 | GO:0000902 |
| GeneOntologyBiologicalProcess | neuron development | TANC2 BOC PRTG KCNIP2 TENM2 COBL KIF5A HERC1 PLXNA2 NOTCH2 SYNE1 OBSL1 LAMA5 LAMB3 FRYL EDNRA PTPN5 PLEKHG4B BCL11B TENM3 TIAM1 SIPA1L1 RP1L1 TET1 DOCK7 PLXNA4 TENM1 ROBO1 RND2 SCRIB CTNND2 ATP2B2 TP73 EPHA8 | 5.24e-05 | 1463 | 234 | 34 | GO:0048666 |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | RALGAPA1 APC2 TBC1D4 RIPOR1 DOCK6 PLXNA2 ARAP1 TIAM1 SIPA1L1 DOCK7 PLXNA4 SCRIB EVI5L | 1.26e-04 | 335 | 234 | 13 | GO:0043087 |
| GeneOntologyBiologicalProcess | neuron projection development | TANC2 BOC PRTG TENM2 COBL KIF5A HERC1 PLXNA2 NOTCH2 SYNE1 OBSL1 LAMA5 LAMB3 FRYL EDNRA PTPN5 PLEKHG4B BCL11B TENM3 TIAM1 SIPA1L1 TET1 DOCK7 PLXNA4 ROBO1 RND2 SCRIB CTNND2 ATP2B2 EPHA8 | 1.39e-04 | 1285 | 234 | 30 | GO:0031175 |
| GeneOntologyBiologicalProcess | axon development | BOC PRTG TENM2 COBL KIF5A PLXNA2 NOTCH2 LAMA5 LAMB3 EDNRA PLEKHG4B BCL11B TIAM1 SIPA1L1 DOCK7 PLXNA4 ROBO1 RND2 EPHA8 | 1.42e-04 | 642 | 234 | 19 | GO:0061564 |
| Domain | Tox-GHH_dom | 7.50e-06 | 4 | 232 | 3 | IPR028916 | |
| Domain | Tox-GHH | 7.50e-06 | 4 | 232 | 3 | PF15636 | |
| Domain | Ten_N | 7.50e-06 | 4 | 232 | 3 | IPR009471 | |
| Domain | Ten_N | 7.50e-06 | 4 | 232 | 3 | PF06484 | |
| Domain | TENEURIN_N | 7.50e-06 | 4 | 232 | 3 | PS51361 | |
| Domain | YD | 1.86e-05 | 5 | 232 | 3 | IPR006530 | |
| Domain | Cobl | 1.54e-04 | 2 | 232 | 2 | PF09469 | |
| Domain | CSTF2_hinge | 1.54e-04 | 2 | 232 | 2 | PF14327 | |
| Domain | CSTF_C | 1.54e-04 | 2 | 232 | 2 | PF14304 | |
| Domain | CSTF2_hinge | 1.54e-04 | 2 | 232 | 2 | IPR025742 | |
| Domain | Cordon-bleu_ubiquitin_domain | 1.54e-04 | 2 | 232 | 2 | IPR019025 | |
| Domain | CSTF_C | 1.54e-04 | 2 | 232 | 2 | IPR026896 | |
| Domain | Galactose-bd-like | 1.71e-04 | 94 | 232 | 7 | IPR008979 | |
| Domain | ZF_CXXC | 2.90e-04 | 11 | 232 | 3 | PS51058 | |
| Domain | Znf_CXXC | 2.90e-04 | 11 | 232 | 3 | IPR002857 | |
| Domain | zf-CXXC | 2.90e-04 | 11 | 232 | 3 | PF02008 | |
| Domain | Rhs_assc_core | 4.57e-04 | 3 | 232 | 2 | IPR022385 | |
| Domain | RIG-I_C-RD | 4.57e-04 | 3 | 232 | 2 | IPR021673 | |
| Domain | PL48 | 4.57e-04 | 3 | 232 | 2 | PF15903 | |
| Domain | FAM65_N | 4.57e-04 | 3 | 232 | 2 | IPR031780 | |
| Domain | FAM65 | 4.57e-04 | 3 | 232 | 2 | IPR026136 | |
| Domain | RIG-I_C-RD | 4.57e-04 | 3 | 232 | 2 | PF11648 | |
| Domain | - | 4.57e-04 | 3 | 232 | 2 | 1.10.1580.10 | |
| Domain | RLR_CTR | 4.57e-04 | 3 | 232 | 2 | PS51789 | |
| Domain | NHL | 4.94e-04 | 13 | 232 | 3 | PS51125 | |
| Domain | ATP_Ca_trans_C | 9.07e-04 | 4 | 232 | 2 | IPR022141 | |
| Domain | ATP_Ca_trans_C | 9.07e-04 | 4 | 232 | 2 | PF12424 | |
| Domain | C5_MTASE_1 | 9.07e-04 | 4 | 232 | 2 | PS00094 | |
| Domain | C5_MTASE_2 | 9.07e-04 | 4 | 232 | 2 | PS00095 | |
| Domain | SAM_MT_C5 | 9.07e-04 | 4 | 232 | 2 | PS51679 | |
| Domain | DNA_methylase | 9.07e-04 | 4 | 232 | 2 | PF00145 | |
| Domain | C5_MeTfrase | 9.07e-04 | 4 | 232 | 2 | IPR001525 | |
| Domain | C5_DNA_meth_AS | 9.07e-04 | 4 | 232 | 2 | IPR018117 | |
| Domain | P-type_ATPase_IIB | 9.07e-04 | 4 | 232 | 2 | IPR006408 | |
| Domain | GTP-bd_ortho_bundle | 9.07e-04 | 4 | 232 | 2 | IPR023179 | |
| Domain | P-loop_NTPase | TANC2 KIF21B MYO1C LSG1 SRCAP IFIH1 ABCD3 GNL2 NAV3 DHX35 KIF5A DDX24 DYNC1H1 KIF22 NWD1 DHX58 NSF MTHFD1L MYO18A CHTF18 MYH15 RND2 | 9.21e-04 | 848 | 232 | 22 | IPR027417 |
| Domain | fn3 | 9.64e-04 | 162 | 232 | 8 | PF00041 | |
| Domain | CarboxyPept-like_regulatory | 1.13e-03 | 17 | 232 | 3 | IPR008969 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | RALGAPA1 CDC42EP4 ANLN ABCD3 DOCK6 ARAP1 VRK2 LETM1 PLEKHG4B ARFGAP2 TIAM1 VANGL1 MACO1 DOCK7 COPS4 RND2 SCRIB SPATA13 | 1.46e-05 | 450 | 177 | 18 | M27078 |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | CDC42EP4 DOCK6 ARAP1 PLEKHG4B ARFGAP2 TIAM1 VANGL1 DOCK7 SCRIB SPATA13 | 2.58e-05 | 155 | 177 | 10 | M41808 |
| Pubmed | EPHB4 RALGAPA1 LSG1 ZC3H13 NCLN ELAC2 WDR3 GLB1 PIK3C2A UBR5 TUBGCP3 ABCD3 GNL2 DNAJB2 DDX24 ANKRD52 NOTCH2 DNMT1 VRK2 TCHP NSF MTHFD1L ST7 SYNE1 COX5B RANBP3 MYO18A OBSL1 LETM1 SLC4A2 WDR19 LSR EXOC5 TIAM1 VANGL1 MACO1 COPS4 EFR3B ROBO1 SCRIB SLIRP ATP2B4 | 7.18e-15 | 1487 | 240 | 42 | 33957083 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TANC2 RALGAPA1 CDC42EP4 LSG1 C19orf47 TBC1D4 PIK3C2A ANLN COBL DOCK6 UTRN NOTCH2 DNMT1 TCF20 RANBP3 COBLL1 FRYL ARFGAP2 LSR TIAM1 AASS SLC25A1 SIPA1L1 TET1 DOCK7 SCRIB CEP170B SPATA13 | 1.35e-11 | 861 | 240 | 28 | 36931259 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPHB4 TANC2 INTS1 C19orf47 NCLN SRCAP ELAC2 TYK2 FZR1 TNRC18 NCAPD2 COBL RIPOR1 HERC1 DOCK6 GCN1 DYNC1H1 NOTCH2 ARAP1 PITPNM2 MTHFD1L POLR2A LAMA5 LAMB3 AMBRA1 FRYL NCOR2 SLC16A5 CEP170B EVI5L SPATA13 | 4.16e-11 | 1105 | 240 | 31 | 35748872 |
| Pubmed | TANC2 MYO1C LSG1 PHF8 SRCAP RCOR2 TYK2 ATXN7L3 UBR5 TUBGCP3 NFKBIL1 GNL2 DDX24 ANKRD52 NOTCH2 POLR2A RANBP9 OBSL1 AMBRA1 GADD45GIP1 NCOR2 BCL11B VANGL1 SIPA1L1 SCRIB LONRF3 PCCA VPS53 CEP170B EVI5L TP73 | 5.32e-11 | 1116 | 240 | 31 | 31753913 | |
| Pubmed | PHF8 TENM2 UBR5 NAV3 COBL RIPOR1 BAIAP3 TET3 DYNC1H1 PLXNA2 TCF20 SYNE1 OBSL1 TENM3 SIPA1L1 DOCK7 SCRIB CEP170B SPATA13 | 8.17e-11 | 407 | 240 | 19 | 12693553 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | HK2 MYO1C LSG1 PSMA6 PHF8 SRCAP CXXC1 ELAC2 WDR3 TBC1D4 PIK3C2A UBR5 ANLN TUBGCP3 NCAPD2 ABCD3 PKP1 DDX24 GCN1 ANKRD52 UTRN DYNC1H1 DNMT1 TCF20 TCP1 MTHFD1L POLR2A RANBP9 AMBRA1 RIN1 NCOR2 SLC25A1 CHTF18 SCRIB | 8.26e-11 | 1353 | 240 | 34 | 29467282 |
| Pubmed | TTC39B PSMA6 CYP27A1 SORCS1 UBR5 ABCD3 COBL RIPOR1 DDX24 DYNC1H1 RC3H2 NSF MTHFD1L SYNE1 POLR2A MYO18A LAMA5 MORC2 SLC1A6 LETM1 NCOR2 ARFGAP2 COPS4 RBM6 | 6.53e-10 | 754 | 240 | 24 | 35906200 | |
| Pubmed | RALGAPA1 MYO1C PHF8 TBC1D4 ABCD3 GNL2 HERC1 GCN1 ANKRD52 UTRN DNMT1 KIF22 VRK2 TCP1 ST7 POLR2A LETM1 PTPN5 NCOR2 TIAM1 VANGL1 MACO1 EFR3B CSTF2 ROBO1 SCRIB ATP2B4 CBX8 | 1.19e-09 | 1049 | 240 | 28 | 27880917 | |
| Pubmed | HK2 GALNT2 MYO1C PSMA6 NCLN WDR3 PIK3C2A UBR5 NCAPD2 ABCD3 GNL2 COBL DDX24 GCN1 DYNC1H1 DHX58 TCP1 NSF MTHFD1L ST7 DUT RANBP9 LETM1 EXOC5 AASS MACO1 SIPA1L1 DOCK7 SCRIB SLIRP VPS53 EVI5L | 6.21e-09 | 1440 | 240 | 32 | 30833792 | |
| Pubmed | HK2 GALNT2 LSG1 NCLN TYK2 GLB1 TUBGCP3 ABCD3 DNMT1 RC3H2 TCP1 OBSL1 LAMB3 AMBRA1 MORC2 LETM1 SLC4A2 ARFGAP2 CHTF18 DOCK7 SCRIB | 6.23e-09 | 650 | 240 | 21 | 38777146 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | MYO1C PSMA6 WDR3 ATXN7L3 PIK3C2A UBR5 TUBGCP3 ABCD3 GNL2 PKP1 DDX24 GCN1 ANKRD52 UTRN DNMT1 USP49 NSF MTHFD1L RANBP9 AMBRA1 KRT79 SIPA1L1 DOCK7 COPS4 SCRIB SLIRP | 9.18e-09 | 1005 | 240 | 26 | 19615732 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | GALNT2 INTS1 C19orf47 NCLN SRCAP WDR3 UBR5 ABCD3 GNL2 PKP1 GCN1 UTRN DYNC1H1 KIF22 TCF20 TCP1 NSF SYNE1 POLR2A OBSL1 GADD45GIP1 LSR VANGL1 DOCK7 CSTF2 SCRIB | 1.34e-08 | 1024 | 240 | 26 | 24711643 |
| Pubmed | TANC2 KIF21B LSG1 APC2 TENM2 RCOR2 UBR5 KIF5A DYNC1H1 DNMT1 CACNA1E TCF20 NSF SYNE1 RANBP9 LETM1 NCOR2 BCL11B SIPA1L1 DOCK7 SCRIB CTNND2 ATP2B4 CEP170B SPATA13 | 1.69e-08 | 963 | 240 | 25 | 28671696 | |
| Pubmed | MYO1C PSMA6 UBR5 NCAPD2 DOCK6 DDX24 GCN1 DYNC1H1 DNMT1 KIF22 NSF VANGL1 SIPA1L1 DOCK7 COPS4 ROBO1 | 2.25e-08 | 399 | 240 | 16 | 37536630 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | CXXC1 WDR3 ABCD3 GNL2 DDX24 UTRN VRK2 TCP1 MTHFD1L LAMB3 ARFGAP2 CHTF18 SIPA1L1 DOCK7 SCRIB VPS53 | 3.28e-08 | 410 | 240 | 16 | 26949251 |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | EPHB4 TANC2 CDC42EP4 GALNT2 IREB2 UBR5 COBL HERC1 UTRN NOTCH2 SYNE1 MYO18A RIN1 TENM3 MACO1 FLAD1 EFR3B ROBO1 SCRIB SLIRP ATP2B4 | 3.51e-08 | 719 | 240 | 21 | 35337019 |
| Pubmed | EHMT2 directs DNA methylation for efficient gene silencing in mouse embryos. | 4.26e-08 | 15 | 240 | 5 | 26576615 | |
| Pubmed | PHF8 SRCAP ANLN NCAPD2 GCN1 DYNC1H1 CSTF2T DNMT1 TCF20 TCP1 RANBP3 POLR2A SLC25A1 TET1 DOCK7 CSTF2 SCRIB PCCA | 6.30e-08 | 549 | 240 | 18 | 38280479 | |
| Pubmed | CDC42EP4 MYO1C LSG1 CALHM1 WDR3 UBR5 ABCD3 GCN1 DYNC1H1 NOTCH2 DNMT1 TCP1 MAGEC3 ARFGAP2 LSR TENM3 VANGL1 DOCK7 ROBO1 SCRIB PCCA | 1.29e-07 | 777 | 240 | 21 | 35844135 | |
| Pubmed | DNA methyltransferase 3b regulates articular cartilage homeostasis by altering metabolism. | 1.51e-07 | 8 | 240 | 4 | 28614801 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | LSG1 ZC3H13 INTS1 SRCAP CXXC1 RCOR2 TUBGCP3 ABCD3 GNL2 DHX35 DOCK6 DDX24 GCN1 DYNC1H1 CSTF2T DNMT3A TCF20 SYNE1 POLR2A MYO18A SLC25A1 DOCK7 RBM6 CSTF2 CBX8 | 1.56e-07 | 1082 | 240 | 25 | 38697112 |
| Pubmed | MYO1C ZC3H13 INTS1 WDR3 UBR5 NCAPD2 GNL2 DDX24 GCN1 ANKRD52 UTRN DYNC1H1 DNMT1 TCF20 MTHFD1L POLR2A FRYL DOCK7 RBM6 | 1.71e-07 | 653 | 240 | 19 | 22586326 | |
| Pubmed | LSG1 INTS1 WDR3 ATXN7L3 PIK3C2A ANLN NCAPD2 ABCD3 GNL2 UTRN CSTF2T KIF22 VRK2 NSF MTHFD1L SYNE1 NTHL1 COX5B POLR2A LAMA5 MORC2 LSR VANGL1 SLC25A1 MACO1 SIPA1L1 RBM6 CTNND2 CEP170B CBX8 | 1.83e-07 | 1497 | 240 | 30 | 31527615 | |
| Pubmed | LSG1 TBC1D4 UBR5 COBL UTRN RC3H2 SIPA1L1 DOCK7 ROBO1 SCRIB CEP170B | 2.58e-07 | 209 | 240 | 11 | 36779422 | |
| Pubmed | TET1 regulates fibroblast growth factor 8 transcription in gonadotropin releasing hormone neurons. | 2.71e-07 | 9 | 240 | 4 | 31361780 | |
| Pubmed | 3.25e-07 | 3 | 240 | 3 | 33803994 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | APC2 KDM5D TNRC18 AEBP1 NFKBIL1 SCN10A DYNC1H1 ARAP1 RANBP3 TMEM151B PLEKHG4B NCOR2 USF3 SETBP1 TP73 | 3.73e-07 | 430 | 240 | 15 | 35044719 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | KIF21B NCLN IFIH1 NCAPD2 GNL2 COBL HERC1 DDX24 NWD1 COL6A6 MTHFD1L POLR2A MORC2 COPS4 CSTF2 MUC4 | 4.42e-07 | 497 | 240 | 16 | 36774506 |
| Pubmed | 4.93e-07 | 100 | 240 | 8 | 10048485 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | MYO1C ZC3H13 PHF8 TBC1D4 ANLN RIPOR1 DDX24 CSTF2T NOTCH2 DNMT1 TCF20 POLR2A MYO18A MORC2 PITPNM1 NCOR2 CHTF18 SIPA1L1 RBM6 SCRIB | 5.24e-07 | 774 | 240 | 20 | 15302935 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | RALGAPA1 GALNT2 INPP4A KCNIP2 TYK2 TNRC18 TBC1D4 TGFBRAP1 COBL RIPOR1 DOCK6 BAIAP3 UTRN TET3 NOTCH2 ARAP1 PITPNM2 SPATA6 TCHP ST7 FRYL PLEKHG4B NCOR2 USF3 SETBP1 RBM6 PCCA CEP170B EVI5L | 5.35e-07 | 1489 | 240 | 29 | 28611215 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | HK2 MYO1C LSG1 PSMA6 NCLN ELAC2 WDR3 PIK3C2A ABCD3 GNL2 DHX35 HERC1 DDX24 DHTKD1 VRK2 TCP1 MTHFD1L ST7 SYNE1 COX5B OBSL1 THUMPD1 GADD45GIP1 LETM1 AASS VANGL1 MACO1 FLAD1 SLIRP | 5.88e-07 | 1496 | 240 | 29 | 32877691 |
| Pubmed | TANC2 RALGAPA1 TBC1D4 PIK3C2A UBR5 DOCK6 ANKRD52 UTRN NOTCH2 TCHP FRYL LETM1 SIPA1L1 DOCK7 CEP170B | 5.91e-07 | 446 | 240 | 15 | 24255178 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | RALGAPA1 UBR5 PKP1 DYNC1H1 PITPNM2 CACNA1E SYNE1 PITPNM1 SIPA1L1 CTNND2 CEP170B EVI5L | 6.90e-07 | 281 | 240 | 12 | 28706196 |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | EPHB4 HK2 GALNT2 NCLN GLB1 UBR5 NCAPD2 ABCD3 DNAJB2 GCN1 DYNC1H1 DNMT1 VRK2 NSF OBSL1 SLC4A2 LSR SLC25A1 CSTF2 SCRIB VPS53 ATP2B4 | 7.56e-07 | 942 | 240 | 22 | 31073040 |
| Pubmed | TANC2 RALGAPA1 MYO1C INPP4A PSMA6 GJA3 ABCD3 UTRN DYNC1H1 PITPNM2 TCP1 NSF SYNE1 PPFIA4 MYO18A KRT79 LETM1 PITPNM1 RIN1 SLC8A2 SIPA1L1 DOCK7 PLXNA4 SCRIB CTNND2 ATP2B2 ATP2B4 CEP170B | 7.80e-07 | 1431 | 240 | 28 | 37142655 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | MYO1C PSMA6 KCNIP2 ELAC2 TBC1D4 GLB1 UBR5 NFKBIL1 ABCD3 GNL2 HERC1 DDX24 GCN1 DYNC1H1 NSF MTHFD1L NTHL1 COX5B RANBP3 POLR2A RANBP9 FRYL LSR TIAM1 SLC25A1 COPS4 | 1.06e-06 | 1284 | 240 | 26 | 17353931 |
| Pubmed | GALNT2 APC2 NCKAP5 WDR3 NAV3 DHX35 KIF5A DNAJB2 UTRN UAP1L1 DYNC1H1 DNMT1 ZCCHC12 SYNE1 RANBP9 OBSL1 SEC31B WDR19 TIAM1 SIPA1L1 COPS4 ROBO1 SPRED1 SCRIB CTNND2 SMAD2 | 1.08e-06 | 1285 | 240 | 26 | 35914814 | |
| Pubmed | HK2 PSMA6 TBC1D4 UBR5 DNAJB2 GCN1 DYNC1H1 MTHFD1L COX5B POLR2A AMBRA1 LETM1 SLC25A1 DOCK7 SCRIB SLIRP | 1.13e-06 | 534 | 240 | 16 | 35032548 | |
| Pubmed | Mouse ten-m/Odz is a new family of dimeric type II transmembrane proteins expressed in many tissues. | 1.29e-06 | 4 | 240 | 3 | 10225957 | |
| Pubmed | De novo DNA methylation drives 5hmC accumulation in mouse zygotes. | 1.29e-06 | 4 | 240 | 3 | 26751286 | |
| Pubmed | All four members of the Ten-m/Odz family of transmembrane proteins form dimers. | 1.29e-06 | 4 | 240 | 3 | 12000766 | |
| Pubmed | INPP4A RCOR2 TBC1D4 UBR5 ABCD3 GCN1 ANKRD52 UTRN CSTF2T TCF20 NCOR2 TET1 DOCK7 PCCA | 1.48e-06 | 418 | 240 | 14 | 34709266 | |
| Pubmed | TANC2 PSMA6 ABCD3 COBL DOCK6 GCN1 UTRN ARAP1 DUT RANBP9 PLEKHG4B TIAM1 MACO1 DOCK7 RBM6 CSTF2 ROBO1 SCRIB SLIRP EVI5L SPATA13 | 1.82e-06 | 916 | 240 | 21 | 32203420 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | MYO1C TBC1D4 ABCD3 COBL TCP1 MYO18A MORC2 SIPA1L1 DOCK7 SCRIB | 2.07e-06 | 208 | 240 | 10 | 33230847 |
| Pubmed | HK2 GALNT2 MYO1C SPN LSG1 INTS1 NCLN PIK3C2A UBR5 TUBGCP3 NCAPD2 ABCD3 GNL2 KIF5A DDX24 GCN1 DYNC1H1 NOTCH2 MTHFD1L MYO18A SLC4A2 NCOR2 CHTF18 ATP2B4 | 2.20e-06 | 1168 | 240 | 24 | 19946888 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | HK2 MYO1C PSMA6 INTS1 NCLN ELAC2 WDR3 UBR5 ABCD3 DNAJB2 GCN1 DYNC1H1 VRK2 ZCCHC12 TCP1 NSF MTHFD1L POLR2A AMBRA1 AASS SLC25A1 CHTF18 RLIM SCRIB SLIRP | 2.38e-06 | 1257 | 240 | 25 | 37317656 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | HK2 TRAPPC13 TBC1D4 UBR5 NCAPD2 PKP1 DDX24 ANKRD52 DYNC1H1 NOTCH2 KIF22 NSF POLR2A OBSL1 THUMPD1 MORC2 GADD45GIP1 NCOR2 SCRIB SMAD2 | 2.48e-06 | 857 | 240 | 20 | 25609649 |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | CDC42EP4 ANLN UTRN NOTCH2 VRK2 TIAM1 VANGL1 DOCK7 EFR3B ROBO1 SPRED1 SCRIB ATP2B4 | 2.57e-06 | 377 | 240 | 13 | 38117590 |
| Pubmed | 2.69e-06 | 125 | 240 | 8 | 29467281 | ||
| Pubmed | TET2 catalyzes active DNA demethylation of the Sry promoter and enhances its expression. | 2.84e-06 | 15 | 240 | 4 | 31530896 | |
| Pubmed | USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c. | 3.13e-06 | 90 | 240 | 7 | 35654790 | |
| Pubmed | 3.21e-06 | 5 | 240 | 3 | 20889571 | ||
| Pubmed | LSG1 UBR5 DHTKD1 ANKRD52 UTRN MTHFD1L COX5B POLR2A LETM1 AASS CHTF18 FLAD1 DOCK7 SLIRP VPS53 | 3.47e-06 | 515 | 240 | 15 | 31617661 | |
| Pubmed | PHF8 UBR5 GCN1 BAIAP3 ARAP1 SYNE1 OBSL1 SIPA1L1 SETBP1 SCRIB | 4.16e-06 | 225 | 240 | 10 | 12168954 | |
| Pubmed | TANC2 HK2 NCLN TENM2 TNRC18 ABCD3 NAV3 PKP1 DNAJB2 GCN1 PITPNM2 COX5B RANBP9 MYO18A PITPNM1 ARFGAP2 SIPA1L1 DOCK7 TENM1 CTNND2 SLIRP PCCA CEP170B | 4.81e-06 | 1139 | 240 | 23 | 36417873 | |
| Pubmed | RALGAPA1 GALNT2 PHF8 GLB1 OSBPL7 ANKRD52 NOTCH2 DNMT1 COX5B POLR2A DUT RANBP9 EXOC5 VANGL1 RBM6 | 5.25e-06 | 533 | 240 | 15 | 25544563 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | TANC2 NCLN TBC1D4 GLB1 NFKBIL1 ABCD3 RIPOR1 DDX24 GCN1 DYNC1H1 TCHP NSF COBLL1 RANBP9 OBSL1 AMBRA1 WDR19 RIN1 EXOC5 TIAM1 SIPA1L1 DOCK7 COPS4 ATP2B2 VPS53 | 5.65e-06 | 1321 | 240 | 25 | 27173435 |
| Pubmed | FDX2 KIF5A DNAJB2 TET3 UAP1L1 CACNA1E TCF20 SYNE1 NTHL1 MACO1 | 5.67e-06 | 233 | 240 | 10 | 37704626 | |
| Pubmed | RALGAPA1 HK2 MYO1C PSMA6 TBC1D4 UBR5 UTRN DYNC1H1 TCP1 PPWD1 NCOR2 ARFGAP2 CHTF18 PCCA ATP2B2 | 5.86e-06 | 538 | 240 | 15 | 28524877 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | HK2 LSG1 NCLN ELAC2 TBC1D4 HYPK UBR5 NCAPD2 ABCD3 GNL2 PKP1 DDX24 GCN1 DYNC1H1 DNMT1 TCP1 MTHFD1L POLR2A DUT RANBP9 KRT79 PPWD1 LETM1 SLC25A1 CHTF18 SLIRP | 6.13e-06 | 1415 | 240 | 26 | 28515276 |
| Pubmed | 6.27e-06 | 18 | 240 | 4 | 27895551 | ||
| Pubmed | 6.39e-06 | 6 | 240 | 3 | 32147726 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | TANC2 LSG1 INPP4A TUBGCP3 NAV3 PKP1 DNMT1 PITPNM2 CACNA1E TCP1 POLR2A MORC2 NCOR2 SIPA1L1 | 6.45e-06 | 475 | 240 | 14 | 31040226 |
| Pubmed | CDC42EP4 NCKAP5 NAV3 COBL KIF5A GCN1 VRK2 TCF20 SYNE1 COBLL1 RANBP9 MYO18A USF3 ROBO1 | 8.35e-06 | 486 | 240 | 14 | 20936779 | |
| Pubmed | CDC42EP4 GLB1 COBL UTRN NOTCH2 LSR TENM3 VANGL1 EFR3B ROBO1 SCRIB ATP2B4 SMAD2 | 8.46e-06 | 421 | 240 | 13 | 36976175 | |
| Pubmed | RALGAPA1 LSG1 PSMA6 NCAPD2 ABCD3 GCN1 DYNC1H1 TCP1 NSF COBLL1 LETM1 ARFGAP2 VANGL1 DOCK7 EFR3B ROBO1 SCRIB | 9.99e-06 | 708 | 240 | 17 | 39231216 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | MYO1C PSMA6 PIK3C2A ANLN NCAPD2 PKP1 DNAJB2 DDX24 GCN1 UTRN DNMT1 TCP1 NSF MTHFD1L RANBP3 MYO18A THUMPD1 FRYL NCOR2 MYG1 SLC25A1 CHTF18 ZFYVE19 SCRIB PCCA | 1.01e-05 | 1367 | 240 | 25 | 32687490 |
| Pubmed | LSG1 PSMA6 IREB2 CIDEA WDR3 PIK3C2A TUBGCP3 GPATCH11 GNL2 GCN1 DYNC1H1 DNMT1 RC3H2 VRK2 TCP1 NTHL1 COBLL1 OBSL1 MORC2 GADD45GIP1 SLC25A1 DOCK7 SLIRP ATP2B4 CBX8 | 1.06e-05 | 1371 | 240 | 25 | 36244648 | |
| Pubmed | LSG1 TUBGCP3 RC3H2 TCHP ARFGAP2 MACO1 SIPA1L1 EFR3B VPS53 CEP170B | 1.09e-05 | 251 | 240 | 10 | 29778605 | |
| Pubmed | Dynamics of DNA hydroxymethylation and methylation during mouse embryonic and germline development. | 1.11e-05 | 7 | 240 | 3 | 36539615 | |
| Pubmed | High paternal homocysteine causes ventricular septal defects in mouse offspring. | 1.11e-05 | 7 | 240 | 3 | 38523790 | |
| Pubmed | 1.11e-05 | 7 | 240 | 3 | 12915301 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.24e-05 | 202 | 240 | 9 | 33005030 | |
| Pubmed | EPHB4 GALNT2 MYO1C NCLN ELAC2 WDR3 TBC1D4 GLB1 UBR5 ANLN DYNC1H1 NOTCH2 DNMT1 KIF22 VRK2 COL12A1 TCP1 MTHFD1L LAMA5 VANGL1 COPS4 ROBO1 RCN3 SMAD2 | 1.27e-05 | 1297 | 240 | 24 | 33545068 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | PSMA6 NCLN TYK2 UBR5 ABCD3 KIF5A GCN1 ANKRD52 UTRN NSF MTHFD1L RANBP9 OBSL1 AMBRA1 PTPN5 LSR VANGL1 MACO1 FLAD1 SMAD2 | 1.62e-05 | 974 | 240 | 20 | 28675297 |
| Pubmed | INPP4A UBR5 HERC1 DNAJB2 UTRN DYNC1H1 NOTCH2 RANBP9 LAMA5 NCOR2 MYG1 TENM3 MACO1 SPRED1 SMAD2 | 1.77e-05 | 591 | 240 | 15 | 15231748 | |
| Pubmed | 1.77e-05 | 8 | 240 | 3 | 10331952 | ||
| Pubmed | Def-2, -3, -6 and -8, novel mouse genes differentially expressed in the haemopoietic system. | 1.77e-05 | 8 | 240 | 3 | 10460589 | |
| Pubmed | FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells. | 1.82e-05 | 212 | 240 | 9 | 33462405 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | HK2 MYO1C LSG1 PSMA6 NCLN WDR3 NCAPD2 ABCD3 GNL2 PKP1 DDX24 GCN1 DYNC1H1 DNMT1 MCOLN2 TCP1 NSF MTHFD1L SYNE1 POLR2A DUT LETM1 DOCK7 COPS4 SLIRP | 2.03e-05 | 1425 | 240 | 25 | 30948266 |
| Pubmed | 2.11e-05 | 24 | 240 | 4 | 23920106 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | HK2 SRCAP ELAC2 ANLN NCAPD2 GCN1 DYNC1H1 DNMT1 TCP1 POLR2A MYG1 | 2.21e-05 | 332 | 240 | 11 | 32786267 |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | RALGAPA1 GALNT2 NCLN UBR5 TUBGCP3 GNL2 DOCK6 GCN1 DNMT1 NSF RANBP9 MYO18A AASS MACO1 ATP2B4 CBX8 SMAD2 | 2.23e-05 | 754 | 240 | 17 | 33060197 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | TYK2 WDR3 TNRC18 ANLN DNMT1 RC3H2 TCF20 TCP1 NCOR2 ARFGAP2 BCL11B SLIRP | 2.38e-05 | 398 | 240 | 12 | 35016035 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | PSMA6 INTS1 PHF8 SRCAP ANLN GPATCH11 GNL2 DDX24 DNMT1 KIF22 DNMT3A TCF20 NTHL1 MORC2 CBX8 | 2.46e-05 | 608 | 240 | 15 | 36089195 |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | CDC42EP4 ZNF205 GLB1 ANKRD52 NOTCH2 RANBP3 FRYL NCOR2 TENM3 TIAM1 SIPA1L1 TET1 COPS4 RBM6 | 2.47e-05 | 536 | 240 | 14 | 15840001 |
| Pubmed | CDC42EP4 ZNF205 GLB1 ANKRD52 NOTCH2 RANBP3 FRYL NCOR2 TENM3 TIAM1 SIPA1L1 TET1 COPS4 RBM6 | 2.58e-05 | 538 | 240 | 14 | 10512203 | |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | EPHB4 RALGAPA1 KLHL2 MYO1C ZNF205 FZR1 OSBPL7 BAIAP3 DNMT1 TCP1 KHDC4 SLC4A2 PITPNM1 AASS VANGL1 CHTF18 FLAD1 LONRF3 TP73 | 2.64e-05 | 925 | 240 | 19 | 28986522 |
| Pubmed | INTS1 NCAPD2 UTRN CSTF2T DNMT1 TCP1 POLR2A GADD45GIP1 SLC4A2 EXOC5 COPS4 CSTF2 | 3.25e-05 | 411 | 240 | 12 | 36652389 | |
| Pubmed | TANC2 CDC42EP4 PIK3C2A CACNA1E MYO18A PITPNM1 RIN1 SIPA1L1 CTNND2 ATP2B2 CEP170B | 3.31e-05 | 347 | 240 | 11 | 17114649 | |
| Pubmed | 3.45e-05 | 230 | 240 | 9 | 35449600 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | GLB1 UBR5 ANLN ABCD3 DDX24 GCN1 DYNC1H1 DNMT1 TCP1 MTHFD1L POLR2A THUMPD1 MORC2 SLC25A1 SCRIB SMAD2 | 3.54e-05 | 704 | 240 | 16 | 29955894 |
| Pubmed | METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. | 3.57e-05 | 231 | 240 | 9 | 36597993 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ZC3H13 INTS1 ZNF205 PHF8 NCLN SRCAP CXXC1 WDR3 ATXN7L3 NFKBIL1 DDX24 TET3 DNMT1 KIF22 VRK2 TCF20 NTHL1 POLR2A NCOR2 MACO1 CSTF2 PCCA CBX8 | 3.62e-05 | 1294 | 240 | 23 | 30804502 |
| Pubmed | Dysregulation of the TET family of epigenetic regulators in lymphoid and myeloid malignancies. | 3.76e-05 | 10 | 240 | 3 | 31467060 | |
| Pubmed | 3.76e-05 | 10 | 240 | 3 | 38713721 | ||
| Pubmed | 3.89e-05 | 90 | 240 | 6 | 15033168 | ||
| Pubmed | HK2 LSG1 TMTC2 GLB1 UBR5 PKP1 DDX24 NSF POLR2A MYO18A LAMB3 RIN1 COPS4 ATP2B4 CBX8 | 3.96e-05 | 634 | 240 | 15 | 34591612 | |
| Pubmed | 4.36e-05 | 237 | 240 | 9 | 29564676 | ||
| Interaction | YWHAH interactions | TANC2 RALGAPA1 KIF21B CDC42EP4 LSG1 ZC3H13 C19orf47 IFIH1 FZR1 TBC1D4 PIK3C2A ANLN COBL KIF5A HERC1 DOCK6 UTRN NOTCH2 DNMT1 TCF20 RANBP3 COBLL1 FRYL RIN1 ARFGAP2 LSR TIAM1 AASS SLC25A1 SIPA1L1 TET1 DOCK7 SCRIB CEP170B SPATA13 | 1.01e-07 | 1102 | 239 | 35 | int:YWHAH |
| Interaction | RHOA interactions | EPHB4 RALGAPA1 CDC42EP4 LSG1 RIPOR3 NCLN TENM2 GLB1 PIK3C2A ANLN ABCD3 GCN1 UTRN NOTCH2 KIF22 VRK2 NSF ST7 MYO18A FRYL LETM1 SLC4A2 PITPNM1 LSR TENM3 TIAM1 VANGL1 SLC25A1 MACO1 DOCK7 EFR3B ROBO1 RND2 SCRIB SMAD2 | 7.43e-07 | 1199 | 239 | 35 | int:RHOA |
| Interaction | DDB1 interactions | ZC3H13 PSMA6 PHF8 WDR3 FZR1 UBR5 ANLN TET3 DYNC1H1 DNMT1 DNMT3A COBLL1 POLR2A RANBP9 OBSL1 AMBRA1 LETM1 WDR19 BCL11B ASXL3 TET1 RLIM COPS4 CSTF2 TP73 | 9.24e-07 | 697 | 239 | 25 | int:DDB1 |
| Interaction | CDC42 interactions | EPHB4 TANC2 RALGAPA1 CDC42EP4 GALNT2 MYO1C NCLN PIK3C2A ANLN NCAPD2 ABCD3 COBL UTRN NOTCH2 ARAP1 VRK2 NSF SYNE1 COBLL1 DUT MYO18A FRYL SLC4A2 PLEKHG4B ARFGAP2 LSR TENM3 TIAM1 AASS VANGL1 SLC25A1 MACO1 DOCK7 EFR3B ROBO1 SCRIB SPATA13 | 9.65e-07 | 1323 | 239 | 37 | int:CDC42 |
| Interaction | YWHAQ interactions | TANC2 RALGAPA1 KIF21B TGIF2LY ZC3H13 C19orf47 TBC1D4 PIK3C2A ANLN TUBGCP3 KIF5A DDX24 GCN1 DYNC1H1 DNMT1 TCP1 COBLL1 OBSL1 FRYL LSR SLC8A2 TIAM1 AASS SLC25A1 MACO1 SIPA1L1 TET1 DOCK7 COPS4 SCRIB CEP170B SPATA13 | 3.54e-06 | 1118 | 239 | 32 | int:YWHAQ |
| Interaction | RHOG interactions | EPHB4 RALGAPA1 CDC42EP4 MYO1C LSG1 NCLN UBR5 ABCD3 DHTKD1 NOTCH2 VRK2 NSF MTHFD1L ST7 GADD45GIP1 LETM1 SLC4A2 ARFGAP2 LSR TIAM1 AASS VANGL1 SLC25A1 MACO1 FLAD1 EFR3B SCRIB SLIRP | 3.98e-06 | 910 | 239 | 28 | int:RHOG |
| Interaction | ARF6 interactions | EPHB4 CDC42EP4 MYO1C NCLN ANLN ABCD3 DDX24 DYNC1H1 NOTCH2 VRK2 OBSL1 LETM1 SLC4A2 LSR EXOC5 TIAM1 VANGL1 DOCK7 EFR3B ROBO1 ATP2B4 | 6.91e-06 | 584 | 239 | 21 | int:ARF6 |
| Interaction | RHOB interactions | EPHB4 RALGAPA1 CDC42EP4 MYO1C NCLN TENM2 ANLN COBL HERC1 DDX24 UTRN NOTCH2 NSF DUT MYO18A LSR TENM3 TIAM1 VANGL1 SLC25A1 SIPA1L1 DOCK7 EFR3B ROBO1 SCRIB ATP2B4 | 8.12e-06 | 840 | 239 | 26 | int:RHOB |
| Interaction | RHOD interactions | EPHB4 RALGAPA1 CDC42EP4 MYO1C LSG1 NCLN PIK3C2A ABCD3 UTRN NOTCH2 VRK2 MYO18A LSR VANGL1 SLC25A1 MACO1 DOCK7 EFR3B SCRIB SMAD2 | 1.73e-05 | 572 | 239 | 20 | int:RHOD |
| Interaction | C11orf52 interactions | EPHB4 CDC42EP4 MYO1C UTRN NOTCH2 SLC4A2 LSR TIAM1 VANGL1 DOCK7 EFR3B ROBO1 SCRIB ATP2B4 | 2.23e-05 | 311 | 239 | 14 | int:C11orf52 |
| Interaction | RHOC interactions | EPHB4 LSG1 RIPOR3 NCLN TENM2 FZR1 GLB1 ANLN ABCD3 UTRN NOTCH2 VRK2 NSF DUT LSR VANGL1 SLC25A1 MACO1 ROBO1 SCRIB | 2.32e-05 | 584 | 239 | 20 | int:RHOC |
| Interaction | RHOV interactions | CDC42EP4 MYO1C NCLN PIK3C2A NOTCH2 DUT MYO18A LSR VANGL1 SLC25A1 ROBO1 SCRIB | 3.54e-05 | 243 | 239 | 12 | int:RHOV |
| Interaction | CCDC8 interactions | KLHL2 GALNT2 INTS1 C19orf47 NCLN FZR1 UBR5 PKP1 GCN1 UTRN DYNC1H1 TCP1 NSF POLR2A OBSL1 GADD45GIP1 LSR VANGL1 DOCK7 RND2 SCRIB | 3.88e-05 | 656 | 239 | 21 | int:CCDC8 |
| Interaction | USP53 interactions | 4.06e-05 | 138 | 239 | 9 | int:USP53 | |
| Interaction | DNAJC5 interactions | EPHB4 RALGAPA1 NOTCH2 PPFIA4 MYO18A KHDC4 SLC4A2 LSR EXOC5 TIAM1 VANGL1 EFR3B ROBO1 SCRIB ATP2B4 | 4.90e-05 | 378 | 239 | 15 | int:DNAJC5 |
| Interaction | TNIK interactions | TANC2 LSG1 RCOR2 KIF5A DYNC1H1 CACNA1E NSF SYNE1 RANBP9 NCOR2 BCL11B SIPA1L1 DOCK7 CTNND2 CEP170B | 5.36e-05 | 381 | 239 | 15 | int:TNIK |
| Interaction | RHOF interactions | EPHB4 TANC2 CDC42EP4 MYO1C NCLN PIK3C2A NCAPD2 COBL UTRN NOTCH2 KIF22 VRK2 NSF SLC4A2 LSR TIAM1 VANGL1 SLC25A1 DOCK7 EFR3B SCRIB | 5.60e-05 | 673 | 239 | 21 | int:RHOF |
| Interaction | CALM3 interactions | MYO1C TBC1D4 ANLN ABCD3 RC3H2 RANBP9 MYO18A OBSL1 GADD45GIP1 RLIM DOCK7 SLIRP ATP2B4 EPHA8 | 6.48e-05 | 343 | 239 | 14 | int:CALM3 |
| Interaction | CTNNB1 interactions | TANC2 BOC MYO1C SPN PCP2 APC2 FZR1 UBR5 ANLN ABCD3 UTRN DYNC1H1 DNMT1 KIF22 USP49 TCP1 POLR2A OBSL1 AASS SLC25A1 SIPA1L1 RND2 SCRIB CTNND2 SLIRP SMAD2 EPHA8 | 6.91e-05 | 1009 | 239 | 27 | int:CTNNB1 |
| Interaction | RND2 interactions | EPHB4 NCLN PIK3C2A ABCD3 NOTCH2 KIF22 VRK2 DUT LSR VANGL1 SLC25A1 MACO1 EFR3B ROBO1 RND2 SCRIB | 7.74e-05 | 440 | 239 | 16 | int:RND2 |
| Interaction | SNRNP40 interactions | ZC3H13 PHF8 WDR3 FZR1 UBR5 ANLN GNL2 DHX35 DDX24 RC3H2 TCF20 TCP1 OBSL1 PPWD1 KHDC4 NCOR2 CHTF18 COPS4 RBM6 CBX8 | 7.77e-05 | 637 | 239 | 20 | int:SNRNP40 |
| Interaction | YWHAG interactions | TANC2 RALGAPA1 KIF21B ZC3H13 PSMA6 C19orf47 FZR1 TBC1D4 PIK3C2A ANLN OSBPL7 COBL KIF5A UTRN DYNC1H1 NOTCH2 DNMT1 RC3H2 RANBP3 COBLL1 FRYL RIN1 LSR TIAM1 AASS SIPA1L1 TET1 DOCK7 SCRIB CEP170B SPATA13 | 7.81e-05 | 1248 | 239 | 31 | int:YWHAG |
| Interaction | RHOQ interactions | EPHB4 RALGAPA1 CDC42EP4 NCLN UTRN NOTCH2 NSF MYO18A SLC4A2 LSR TIAM1 VANGL1 SLC25A1 EFR3B ROBO1 SCRIB | 8.16e-05 | 442 | 239 | 16 | int:RHOQ |
| Interaction | YWHAZ interactions | TANC2 RALGAPA1 FZR1 TBC1D4 PIK3C2A ANLN OSBPL7 KIF5A DDX24 DYNC1H1 DNMT1 COL6A6 NSF COBLL1 MYO18A OBSL1 FRYL RIN1 LSR SLC8A2 EXOC5 TIAM1 AASS ASXL3 MACO1 SIPA1L1 DOCK7 ZFYVE19 SCRIB ATP2B2 CEP170B SPATA13 | 9.22e-05 | 1319 | 239 | 32 | int:YWHAZ |
| Interaction | RND3 interactions | EPHB4 RALGAPA1 NCLN NOTCH2 VRK2 MYO18A LSR VANGL1 SLC25A1 ROBO1 RND2 SCRIB | 1.08e-04 | 273 | 239 | 12 | int:RND3 |
| Interaction | MOB3C interactions | PSMA6 UBR5 NCAPD2 DOCK6 DDX24 GCN1 DYNC1H1 DNMT1 NSF VANGL1 SIPA1L1 DOCK7 COPS4 ROBO1 | 1.21e-04 | 364 | 239 | 14 | int:MOB3C |
| Interaction | CTSA interactions | 1.31e-04 | 126 | 239 | 8 | int:CTSA | |
| Interaction | TOP3B interactions | EPHB4 TANC2 MYO1C INTS1 C19orf47 IREB2 NCLN SRCAP ELAC2 TYK2 FZR1 TNRC18 NCAPD2 COBL RIPOR1 HERC1 DOCK6 GCN1 DYNC1H1 NOTCH2 ARAP1 PITPNM2 RC3H2 MTHFD1L POLR2A LAMA5 LAMB3 AMBRA1 FRYL NCOR2 SLC16A5 CEP170B EVI5L SPATA13 | 1.37e-04 | 1470 | 239 | 34 | int:TOP3B |
| Interaction | LCK interactions | EPHB4 MYO1C DOK3 UTRN CSTF2T NOTCH2 TCP1 COBLL1 OBSL1 LSR EXOC5 VANGL1 EFR3B SCRIB CTNND2 SMAD2 | 1.39e-04 | 463 | 239 | 16 | int:LCK |
| Interaction | RHOH interactions | EPHB4 RALGAPA1 CDC42EP4 MYO1C NCLN TENM2 ABCD3 NOTCH2 VRK2 NSF MYO18A LSR VANGL1 SLC25A1 EFR3B ROBO1 SCRIB | 1.40e-04 | 512 | 239 | 17 | int:RHOH |
| Interaction | EGLN3 interactions | HK2 MYO1C LSG1 PHF8 TBC1D4 PIK3C2A UBR5 TUBGCP3 ABCD3 GCN1 ANKRD52 UTRN TET3 DYNC1H1 NOTCH2 TCP1 NSF MTHFD1L POLR2A RANBP9 OBSL1 AMBRA1 HIF3A NCOR2 SLC25A1 CHTF18 DOCK7 ROBO1 SCRIB SLIRP CEP170B | 1.54e-04 | 1296 | 239 | 31 | int:EGLN3 |
| Interaction | CAV1 interactions | EPHB4 RALGAPA1 CDC42EP4 GJA3 ANLN COBL UTRN NOTCH2 COBLL1 SLC4A2 ARFGAP2 LSR TIAM1 VANGL1 SLC25A1 EFR3B ROBO1 RND2 SCRIB ATP2B4 SMAD2 | 1.55e-04 | 724 | 239 | 21 | int:CAV1 |
| Interaction | RAB35 interactions | EPHB4 RALGAPA1 CDC42EP4 MYO1C ABCD3 UTRN NOTCH2 VRK2 SLC4A2 LSR TIAM1 VANGL1 MACO1 DOCK7 EFR3B ROBO1 SCRIB ATP2B4 | 1.77e-04 | 573 | 239 | 18 | int:RAB35 |
| Interaction | PAPOLB interactions | 1.86e-04 | 10 | 239 | 3 | int:PAPOLB | |
| Interaction | TRRAP interactions | TTC39B PSMA6 CYP27A1 SRCAP SORCS1 ATXN7L3 UBR5 ABCD3 COBL RIPOR1 DDX24 DYNC1H1 MTHFD1L SYNE1 MYO18A OBSL1 LAMA5 SLC1A6 LETM1 NCOR2 COPS4 RBM6 | 1.92e-04 | 790 | 239 | 22 | int:TRRAP |
| Interaction | CMKLR1 interactions | 2.02e-04 | 101 | 239 | 7 | int:CMKLR1 | |
| Interaction | RARB interactions | 2.07e-04 | 46 | 239 | 5 | int:RARB | |
| Interaction | RHOJ interactions | EPHB4 RALGAPA1 CDC42EP4 NCLN COBL UTRN NOTCH2 VRK2 NSF OBSL1 SLC4A2 LSR TIAM1 VANGL1 SLC25A1 EFR3B ROBO1 SCRIB SMAD2 | 2.09e-04 | 633 | 239 | 19 | int:RHOJ |
| Interaction | IMMP2L interactions | LSG1 UBR5 DHTKD1 ANKRD52 MTHFD1L COX5B POLR2A LETM1 AASS CHTF18 FLAD1 DOCK7 SLIRP VPS53 | 2.11e-04 | 384 | 239 | 14 | int:IMMP2L |
| Cytoband | 19p13.2 | 3.05e-05 | 229 | 240 | 8 | 19p13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | PCP2 APC2 NCLN TYK2 FZR1 FDX2 DOCK6 DNMT1 NWD1 RANBP3 SLC1A6 GADD45GIP1 ANGPTL6 EVI5L | 9.02e-05 | 797 | 240 | 14 | chr19p13 |
| GeneFamily | Zinc fingers CXXC-type | 2.57e-06 | 12 | 157 | 4 | 136 | |
| GeneFamily | WD repeat domain containing | 4.82e-04 | 262 | 157 | 9 | 362 | |
| GeneFamily | Fibronectin type III domain containing | 5.01e-04 | 160 | 157 | 7 | 555 | |
| GeneFamily | Phosphatidylinositol transfer proteins | 1.10e-03 | 6 | 157 | 2 | 1151 | |
| GeneFamily | ATPases Ca2+ transporting | 2.59e-03 | 9 | 157 | 2 | 1209 | |
| GeneFamily | Plexins | 2.59e-03 | 9 | 157 | 2 | 683 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.84e-03 | 161 | 157 | 6 | 593 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | TANC2 KIF21B INPP4A APC2 DOK3 TENM2 RCOR2 NAV3 HERC1 USP49 CACNA1E ZCCHC12 COL6A6 PPFIA4 LAMA5 SEC31B PTPN5 SLC8A2 BCL11B ASXL3 MACO1 PLXNA4 TENM1 ROBO1 CTNND2 ATP2B2 VPS53 SPATA13 | 1.23e-06 | 1106 | 240 | 28 | M39071 |
| Coexpression | GSE2935_UV_INACTIVATED_VS_LIVE_SENDAI_VIRUS_INF_MACROPHAGE_UP | PIK3C2A DNMT3A PITPNM2 TCF20 ST8SIA1 SLC16A5 TIAM1 SIPA1L1 TET1 SPRED1 | 4.27e-06 | 171 | 240 | 10 | M6316 |
| Coexpression | GSE3565_DUSP1_VS_WT_SPLENOCYTES_DN | PIK3C2A DNMT3A PITPNM2 TCF20 MTHFD1L ST8SIA1 SLC16A5 SIPA1L1 TET1 RCN3 | 6.41e-06 | 179 | 240 | 10 | M6324 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | KIF21B APC2 TENM2 RCOR2 HERC1 PLXNA2 USP49 SEC31B PTPN5 SLC8A2 BCL11B ASXL3 MACO1 PLXNA4 TENM1 ROBO1 | 6.85e-06 | 465 | 240 | 16 | M39066 |
| Coexpression | GSE6259_DEC205_POS_DC_VS_CD4_TCELL_UP | KIF21B IREB2 IFIH1 FZR1 GLB1 NFKBIL1 RANBP9 MORC2 PITPNM1 EXOC5 | 1.62e-05 | 199 | 240 | 10 | M6773 |
| Coexpression | MIKKELSEN_ES_ICP_WITH_H3K4ME3 | SPN LSG1 ZNF205 NCKAP5 EFHB RCOR2 SLC2A10 TRAPPC13 OSBPL7 RIPOR1 OPLAH USP49 PLPP7 MORC2 RIN1 AASS FLAD1 DYNLT4 RCN3 | 4.59e-05 | 728 | 240 | 19 | M2004 |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_DC_UP | 9.33e-05 | 198 | 240 | 9 | M4501 | |
| Coexpression | GSE32423_CTRL_VS_IL7_MEMORY_CD8_TCELL_DN | 9.33e-05 | 198 | 240 | 9 | M5084 | |
| Coexpression | GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_CD8A_DC_UP | KIF21B INPP4A AEBP1 SYNE1 LAMA5 ST8SIA1 SIPA1L1 SETBP1 CSTF2 | 9.69e-05 | 199 | 240 | 9 | M9414 |
| Coexpression | GSE14000_UNSTIM_VS_4H_LPS_DC_TRANSLATED_RNA_UP | 9.69e-05 | 199 | 240 | 9 | M3337 | |
| Coexpression | GSE29164_DAY3_VS_DAY7_UNTREATED_MELANOMA_DN | 9.69e-05 | 199 | 240 | 9 | M8487 | |
| Coexpression | GSE11924_TFH_VS_TH1_CD4_TCELL_UP | GALNT2 ATXN7L3 UAP1L1 ARAP1 RC3H2 ASAH2 POLR2A ST8SIA1 MON1B | 9.69e-05 | 199 | 240 | 9 | M3151 |
| Coexpression | GSE28737_WT_VS_BCL6_HET_FOLLICULAR_BCELL_UP | 1.01e-04 | 200 | 240 | 9 | M9391 | |
| Coexpression | GSE17301_IFNA2_VS_IFNA2_AND_ACD3_ACD28_STIM_CD8_TCELL_UP | 1.01e-04 | 200 | 240 | 9 | M8042 | |
| Coexpression | GSE22025_UNTREATED_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP | 1.01e-04 | 200 | 240 | 9 | M8383 | |
| Coexpression | GSE27786_ERYTHROBLAST_VS_NEUTROPHIL_DN | 1.01e-04 | 200 | 240 | 9 | M4876 | |
| Coexpression | GSE21670_UNTREATED_VS_IL6_TREATED_CD4_TCELL_DN | KIF21B GALNT2 CXXC1 RNF32 SYNE1 PITPNM1 BCL11B SLC16A5 SIPA1L1 | 1.01e-04 | 200 | 240 | 9 | M7441 |
| Coexpression | ROSS_ACUTE_MYELOID_LEUKEMIA_CBF | 1.08e-04 | 82 | 240 | 6 | M7804 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d6.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | TANC2 KIF21B TTC39B SPN NCAPD2 BAIAP3 UTRN NLRC3 KIF22 COBLL1 FRYL BCL11B ATP2B4 RCN3 SPATA13 | 1.78e-05 | 374 | 233 | 15 | GSM538389_500 |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | TMTC2 NCKAP5 IFIH1 UBR5 LAMA5 LAMB3 PLEKHG4B LSR EFR3B RBM6 CEP170B EVI5L | 7.18e-10 | 194 | 240 | 12 | 88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | TMTC2 NCKAP5 IFIH1 UBR5 LAMA5 LAMB3 PLEKHG4B LSR EFR3B RBM6 CEP170B EVI5L | 7.18e-10 | 194 | 240 | 12 | a71728202493d4858342ea2756ea281cd0d99a3a |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | EFCAB5 NMUR1 TENM2 AEBP1 SCN10A NAV3 PLXNA2 COL12A1 ST8SIA1 SLC16A5 ATP2B2 | 1.07e-09 | 158 | 240 | 11 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | EFCAB5 NMUR1 TENM2 AEBP1 SCN10A NAV3 PLXNA2 COL12A1 ST8SIA1 SLC16A5 ATP2B2 | 1.07e-09 | 158 | 240 | 11 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | EFCAB5 SPN INPP4A NMUR1 HERC1 UTRN SYNE1 MYOZ3 LAMB3 SETBP1 ATP2B4 | 1.14e-08 | 198 | 240 | 11 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | HK2 NMUR1 RCOR2 SLC2A10 AEBP1 ANLN COL12A1 EDNRA LOXL1 CHTF18 | 1.85e-08 | 161 | 240 | 10 | a7e09cf2ca6cd70d40d08440fe9c5ab9befa1b79 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | HK2 NMUR1 RCOR2 SLC2A10 AEBP1 ANLN COL12A1 EDNRA LOXL1 CHTF18 | 1.85e-08 | 161 | 240 | 10 | 08920a716f6ec62538e361211455a30ad726d7be |
| ToppCell | cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | EPHB4 KIF21B SRCAP KLHL3 SHPK RIPOR1 VRK2 MYO18A HIF3A SETBP1 | 8.45e-08 | 189 | 240 | 10 | bccb3481ffed597c845fe860da658505316105b5 |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | RALGAPA1 IREB2 PIK3C2A TGFBRAP1 UTRN DYNC1H1 FRYL EXOC5 USF3 VANGL1 | 1.03e-07 | 193 | 240 | 10 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | TTC39B INPP4A HERC1 DDX24 UTRN MCOLN2 SYNE1 FRYL SEC31B BCL11B | 1.03e-07 | 193 | 240 | 10 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.58e-07 | 169 | 240 | 9 | 665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.58e-07 | 169 | 240 | 9 | 6614c9851537e4c21b1e45ff0cc3bad07ef9d034 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-effector_CD4-positive,_alpha-beta_T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.37e-07 | 187 | 240 | 9 | e61c1755531469dd3850c9740474b5ad4e0499c1 | |
| ToppCell | 343B-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 9.15e-07 | 189 | 240 | 9 | c26428871dc3261327d89cacaba6e21e004ff1f3 | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-06 | 141 | 240 | 8 | 4aa4b3476dc5abefbd348353cfe711cd5fe3d52f | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-06 | 141 | 240 | 8 | e40c6f1b7fbaa46b3eaa55f1b37ef360b04370a8 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 1.19e-06 | 195 | 240 | 9 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | (7)_Epithelial-I_(AT1)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.24e-06 | 196 | 240 | 9 | 150554fa06868d29b0608189862eef6505ba757f | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.29e-06 | 197 | 240 | 9 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | LV-09._Endothelium_I|LV / Chamber and Cluster_Paper | 1.29e-06 | 197 | 240 | 9 | f9731d4d636e51b94a96805eee6afe9aedc175e3 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.46e-06 | 200 | 240 | 9 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.41e-06 | 166 | 240 | 8 | 49103b75c3e08656c5774f56fd00d7bd53eefcfb | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.43e-06 | 172 | 240 | 8 | 2b6cd84c946b1e800caba452ae70145ea285fec1 | |
| ToppCell | moderate-Myeloid-pDC|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.19e-06 | 180 | 240 | 8 | 1d8df7df03a71f49d6683554d3c948ce90dda42e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.45e-06 | 181 | 240 | 8 | 12ff56fa2949c8d53360cdf2cacfd326e65b54aa | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.45e-06 | 181 | 240 | 8 | 986c036e656f24fe374807e2711cec9e3c83c892 | |
| ToppCell | facs-Spleen-nan-18m-Lymphocytic-Cd3e_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.71e-06 | 182 | 240 | 8 | da3e9093cba791c7c282eb044656046252a32789 | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.71e-06 | 182 | 240 | 8 | 00a148b1e499bf16325491536d187d4dd6b70c06 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-06 | 184 | 240 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.27e-06 | 184 | 240 | 8 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-06 | 184 | 240 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.27e-06 | 184 | 240 | 8 | bd786db4dc4edae6d5cfc0b69901983dea19f729 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-06 | 184 | 240 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.27e-06 | 184 | 240 | 8 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 7.57e-06 | 185 | 240 | 8 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.87e-06 | 186 | 240 | 8 | 56c139e679d640ea901ead657a8e8887e0fca098 | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 8.19e-06 | 187 | 240 | 8 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 8.73e-06 | 135 | 240 | 7 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.19e-06 | 190 | 240 | 8 | 4836ea19308d2a96694f12ab0653b7ce7b101d2f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 9.92e-06 | 192 | 240 | 8 | 6c106b91e46eabbe686a52a65a9c94ad9cbe9390 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.92e-06 | 192 | 240 | 8 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.92e-06 | 192 | 240 | 8 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.92e-06 | 192 | 240 | 8 | dc40ef2341e5d6a6d479f140e023fe1bf687928d | |
| ToppCell | RV-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.03e-05 | 193 | 240 | 8 | e3fa47e2c7cd8a5b69186711c57751f2296de8ae | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-05 | 193 | 240 | 8 | c7e9e6e4bf5e07c9cbdf1aa7c8828f4b2500e3ff | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.03e-05 | 193 | 240 | 8 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.03e-05 | 193 | 240 | 8 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.03e-05 | 193 | 240 | 8 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.07e-05 | 194 | 240 | 8 | 83863da11dfbe59b2d0a2c08db40b537c150588c | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.07e-05 | 194 | 240 | 8 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | 356C-Epithelial_cells-Epithelial-H_(AT1)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.07e-05 | 194 | 240 | 8 | 4c40d6b50675eae52c419d69e719a9223df02ae3 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-H_(AT1)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.07e-05 | 194 | 240 | 8 | 99a90de637e3babec2131cdd9f05ea965d8a8f30 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.11e-05 | 195 | 240 | 8 | 07a3ef6b0f1201fe2bcb9ea426b8f7a69beb4904 | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 1.11e-05 | 195 | 240 | 8 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.11e-05 | 195 | 240 | 8 | b65511770ed67f7447847e2187555b362988af45 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.11e-05 | 195 | 240 | 8 | 4b9663509cc5e3f409f6d0d37640cb301a827d98 | |
| ToppCell | LV-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.11e-05 | 195 | 240 | 8 | 19e0a6c3eae1615aaa39767300acd937dfcb2a7f | |
| ToppCell | mLN-T_cell-gd_T|T_cell / Region, Cell class and subclass | 1.15e-05 | 196 | 240 | 8 | 8f476408cd5a4ea9d25c763c66565343d7989b38 | |
| ToppCell | IPF-Stromal-Myofibroblast|IPF / Disease state, Lineage and Cell class | 1.15e-05 | 196 | 240 | 8 | 2d0a48e49b3b37bb66e33e74c52915911e1f8a74 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.15e-05 | 196 | 240 | 8 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | primary_visual_cortex|World / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.16e-05 | 141 | 240 | 7 | 605d7b28e99c943f64b4095855a6f9f70e92cb09 | |
| ToppCell | COPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 1.20e-05 | 197 | 240 | 8 | d51f484b4e01ac64233950d0b97fa88825ea1dbb | |
| ToppCell | Bronchial_Brush-Epithelial-Basal_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.20e-05 | 197 | 240 | 8 | f5d87824c0020c95d89e069fd9f70b49e5d5fcea | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 142 | 240 | 7 | 759fbbd15b4fb313bd6269b7f087edafebd530ef | |
| ToppCell | Bronchial_Brush-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.24e-05 | 198 | 240 | 8 | 10a17d7c116dcd6cf847fe6f5d7196d887cad1f9 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.29e-05 | 199 | 240 | 8 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | distal-3-mesenchymal-Myofibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.29e-05 | 199 | 240 | 8 | 1f20addc0d138fec02ed6ca4c518169c568de263 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.29e-05 | 199 | 240 | 8 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 1.29e-05 | 199 | 240 | 8 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.29e-05 | 199 | 240 | 8 | 9846d6a31635fde759d55674631c11ab9270a603 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-DC-DC3-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.29e-05 | 199 | 240 | 8 | 7271dbeca9aa838b88ad44d00059263a29c0316b | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.33e-05 | 200 | 240 | 8 | a9cdddc4e985dae59521e557479c24fcc2ac727d | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.33e-05 | 200 | 240 | 8 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.33e-05 | 200 | 240 | 8 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-OPC_related|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.33e-05 | 200 | 240 | 8 | d46a19274c2836ce7494790ce513764dedcadc79 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.33e-05 | 200 | 240 | 8 | 9719fabddc34051949468a7520289e3c750de4f8 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.33e-05 | 200 | 240 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.33e-05 | 200 | 240 | 8 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6--L3-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.33e-05 | 200 | 240 | 8 | 33b9199e0dfc267e2cea20b82d1c167f8adcc635 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-OPC_related-Oligodendrocyte/OPC|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.33e-05 | 200 | 240 | 8 | 4db894cfb80fd1f9e01133f345eefd78edd4bc43 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.33e-05 | 200 | 240 | 8 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | AT1-AT2_cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 1.39e-05 | 145 | 240 | 7 | cd5de30fd948024e3ad043c9411ce9f2722178b2 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.73e-05 | 150 | 240 | 7 | c922dbb4c9c12ccf08bd5f6168b20606c605d052 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-05 | 155 | 240 | 7 | 90e629681a72baacc7981b82883866a487638dbc | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-05 | 157 | 240 | 7 | ec433d2fe827abdb647be4176c231b7052482b6f | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-1|TCGA-Ovary / Sample_Type by Project: Shred V9 | 3.20e-05 | 165 | 240 | 7 | 2ca1154a8692af311d99a4d3aa2f2ac3d23a4310 | |
| ToppCell | facs|World / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-05 | 171 | 240 | 7 | c9990bc041a632b2f7bbebbfe737772c423d7027 | |
| ToppCell | facs-Spleen-nan-24m-Lymphocytic-Cd3e_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.33e-05 | 173 | 240 | 7 | f2eeff86e7dc7f4e3c36f775777d56685d7096cf | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Mesenchymal-Cilia-bearing_cell|5w / Sample Type, Dataset, Time_group, and Cell type. | 4.33e-05 | 173 | 240 | 7 | d4cbeae262abfa30d8c5452285d3261a96875610 | |
| ToppCell | facs-Spleen-nan-24m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-05 | 174 | 240 | 7 | 096bc6f1889f2bbadfe1e1a3eb6ae569aaa2ee7d | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.65e-05 | 175 | 240 | 7 | 73f25bd54309aed1480ddc44bdab518b17e71f92 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.65e-05 | 175 | 240 | 7 | 65571d775d26a40e979dbf290a8e4320c0d9fb3f | |
| ToppCell | 3'-Adult-Appendix-Epithelial-mature_enterocytic-Colonocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.82e-05 | 176 | 240 | 7 | 23fa02d4c39e0b8faa1658116d50b6233a952ccc | |
| ToppCell | 3'-Adult-Appendix-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.82e-05 | 176 | 240 | 7 | 30adf8f1638c6244586f8101c2590bb964dfae00 | |
| ToppCell | Hippocampus-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Nnat_(Nnat)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.99e-05 | 121 | 240 | 6 | 8334a6b2ced1d6a4808458d6d4232d1b688ba28a | |
| ToppCell | Hippocampus-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Nnat_(Nnat)--|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.99e-05 | 121 | 240 | 6 | 4b33eeed7b70da120133b14d42c104d2461d52dc | |
| ToppCell | Hippocampus-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Nnat_(Nnat)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.99e-05 | 121 | 240 | 6 | a33e4ae0b0efb702db1b646ac0486e3b6ce48457 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Endothelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-05 | 178 | 240 | 7 | 6bef4ef48f649c6e38ae732bc08e6d7814db588b | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.37e-05 | 179 | 240 | 7 | d5763912a4ce7188535675e338799b856edb9dda | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.56e-05 | 180 | 240 | 7 | 62511d76d24b836839c3dcc2bf30485ffe9401e2 | |
| Drug | Ampicillin trihydrate [7177-48-2]; Up 200; 10uM; HL60; HG-U133A | RALGAPA1 INPP4A DOK3 NCLN SRCAP FZR1 TBC1D4 KIF5A DHTKD1 NOTCH2 FSCN3 MORC2 LETM1 | 1.79e-07 | 198 | 238 | 13 | 2030_UP |
| Drug | Antipyrine, 4-hydroxy [1672-63-5]; Up 200; 19.6uM; PC3; HT_HG-U133A | INPP4A PHF8 SRCAP KCNIP2 ARAP1 RNF32 SPATA6 FSCN3 HIF3A EDNRA NCOR2 VPS53 | 1.26e-06 | 198 | 238 | 12 | 4095_UP |
| Drug | Dorzolamide hydrochloride [130693-82-2]; Down 200; 11uM; PC3; HT_HG-U133A | LRFN3 PTGER2 FZR1 TBC1D4 SHPK COBL RIPOR1 DOCK6 UAP1L1 RANBP3 COBLL1 | 7.68e-06 | 197 | 238 | 11 | 5785_DN |
| Drug | Deltaline [6836-11-9]; Down 200; 7.8uM; HL60; HT_HG-U133A | SPN FZR1 TGFBRAP1 DMP1 DOCK6 UTRN SYNE1 RANBP3 LETM1 TFR2 MACO1 | 7.68e-06 | 197 | 238 | 11 | 2171_DN |
| Drug | Denatonium benzoate [3734-33-6]; Down 200; 9uM; MCF7; HT_HG-U133A | EPHB4 SPN ZC3H13 IREB2 CSTF2T ST7 COBLL1 LAMB3 AMBRA1 SIPA1L1 RND2 | 8.06e-06 | 198 | 238 | 11 | 6502_DN |
| Drug | Mafenide hydrochloride [138-37-4]; Down 200; 18uM; MCF7; HT_HG-U133A | SPN INPP4A ZNF205 SRCAP CSTF2T COBLL1 LAMB3 PITPNM1 TENM3 SIPA1L1 RCN3 | 8.45e-06 | 199 | 238 | 11 | 2287_DN |
| Drug | Pentetic acid [67-43-6]; Down 200; 10.2uM; MCF7; HT_HG-U133A | TANC2 ZC3H13 SRCAP FZR1 DNMT3A RANBP3 MYOZ3 EDNRA WDR19 TENM3 VPS53 | 8.87e-06 | 200 | 238 | 11 | 5264_DN |
| Drug | dysprosium | 1.24e-05 | 74 | 238 | 7 | CID000023912 | |
| Drug | prochlorperazine dimaleate salt; Up 200; 10uM; MCF7; HT_HG-U133A | KIF21B DOK3 SRCAP SCN10A SYNE1 MYOZ3 HIF3A EDNRA RND2 ATP2B4 | 3.63e-05 | 192 | 238 | 10 | 5575_UP |
| Drug | Dilazep dihydrochloride [20153-98-4]; Down 200; 6uM; PC3; HT_HG-U133A | 3.79e-05 | 193 | 238 | 10 | 7364_DN | |
| Drug | Acetylsalicylsalicylic acid [530-75-6]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 3.96e-05 | 194 | 238 | 10 | 6778_DN | |
| Drug | 15(S)-15-methyl Prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A | RALGAPA1 UTRN UAP1L1 TNFSF15 ARAP1 ST7 MYOZ3 LETM1 EXOC5 TENM3 | 3.96e-05 | 194 | 238 | 10 | 7494_UP |
| Drug | 3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Up 200; 13.8uM; PC3; HT_HG-U133A | EPHB4 TANC2 FZR1 SCN10A DNMT3A FSCN3 COBLL1 HIF3A RIN1 VPS53 | 4.14e-05 | 195 | 238 | 10 | 4298_UP |
| Drug | Benzathine benzylpenicillin [5928-84-7]; Up 200; 4.2uM; MCF7; HT_HG-U133A | 4.14e-05 | 195 | 238 | 10 | 7359_UP | |
| Drug | Adenosine 5'-monophosphate monohydrate [18422-05-4]; Down 200; 11uM; PC3; HT_HG-U133A | SPN ZNF205 FZR1 SCN10A BAIAP3 EDNRA PITPNM1 AASS CTNND2 VPS53 | 4.32e-05 | 196 | 238 | 10 | 6760_DN |
| Drug | Pindolol [13523-86-9]; Up 200; 16.2uM; PC3; HT_HG-U133A | INPP4A SRCAP SLC2A10 COBL DHX35 TNFSF15 ARAP1 MYOZ3 RIN1 PCCA | 4.51e-05 | 197 | 238 | 10 | 2075_UP |
| Drug | Iproniazide phosphate [305-33-9]; Down 200; 14.4uM; PC3; HT_HG-U133A | INTS1 PHF8 TBC1D4 SHPK UTRN MYOZ3 MORC2 SLC4A2 PITPNM1 BCL11B | 4.51e-05 | 197 | 238 | 10 | 6359_DN |
| Drug | Lithocholic acid [434-13-9]; Down 200; 10.6uM; PC3; HT_HG-U133A | SRCAP BAIAP3 SYNE1 EDNRA PITPNM1 TIAM1 AASS MYH15 VPS53 RCN3 | 4.71e-05 | 198 | 238 | 10 | 4551_DN |
| Drug | Vitamin K2 [11032-49-8]; Down 200; 9uM; PC3; HT_HG-U133A | INPP4A SRCAP TRAPPC13 TBC1D4 NAV3 CSTF2T MORC2 RIN1 MYH15 RCN3 | 4.91e-05 | 199 | 238 | 10 | 4534_DN |
| Drug | Karakoline [39089-30-0]; Down 200; 10.6uM; PC3; HT_HG-U133A | SPN INPP4A SRCAP FZR1 DHX35 SYNE1 RANBP3 COBLL1 PITPNM1 CBX8 | 4.91e-05 | 199 | 238 | 10 | 4297_DN |
| Drug | Suxibuzone [27470-51-5]; Down 200; 9.2uM; HL60; HT_HG-U133A | 4.91e-05 | 199 | 238 | 10 | 2503_DN | |
| Drug | Lobeline alpha (-) hydrochoride [134-63-4]; Up 200; 10.6uM; PC3; HT_HG-U133A | INPP4A SRCAP SCN10A BAIAP3 PLXNA2 PGGHG BCL11B EFR3B ATP2B2 RCN3 | 5.12e-05 | 200 | 238 | 10 | 5784_UP |
| Drug | Glutethimide, para-amino [125-84-8]; Up 200; 17.2uM; MCF7; HT_HG-U133A | SRCAP PTGER2 TGFBRAP1 RIPOR1 DOCK6 PITPNM1 RIN1 NCOR2 TIAM1 RBM6 | 5.12e-05 | 200 | 238 | 10 | 7463_UP |
| Drug | Adiphenine hydrochloride [50-42-0]; Down 200; 11.4uM; HL60; HT_HG-U133A | CDC42EP4 SPN SRCAP FZR1 TGFBRAP1 SHPK DNAJB2 RANBP3 RIN1 CEP170B | 5.12e-05 | 200 | 238 | 10 | 1872_DN |
| Disease | Intellectual Disability | TANC2 RALGAPA1 INPP4A APC2 KCNK4 KIF5A TET3 DYNC1H1 DNMT3A CACNA1E TCF20 NSF SYNE1 LETM1 BCL11B AASS SETBP1 RLIM VPS53 | 3.22e-09 | 447 | 232 | 19 | C3714756 |
| Disease | Seizures | 9.69e-06 | 218 | 232 | 10 | C0036572 | |
| Disease | Global developmental delay | 1.09e-05 | 133 | 232 | 8 | C0557874 | |
| Disease | cystic kidney disease (implicated_via_orthology) | 5.53e-05 | 10 | 232 | 3 | DOID:2975 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | BOC TNFSF13 APC2 ADCY8 KCNA10 ABCD3 MTHFD1L SYNE1 NTHL1 LAMB3 BCL11B TIAM1 SETBP1 TENM1 CTNND2 SMAD2 | 1.53e-04 | 702 | 232 | 16 | C0009402 |
| Disease | endometriosis of uterus (is_marker_for) | 1.84e-04 | 3 | 232 | 2 | DOID:288 (is_marker_for) | |
| Disease | Muscle hypotonia | 3.01e-04 | 17 | 232 | 3 | C0026827 | |
| Disease | psoriasis, type 2 diabetes mellitus | 3.17e-04 | 75 | 232 | 5 | EFO_0000676, MONDO_0005148 | |
| Disease | Clear-cell metastatic renal cell carcinoma | 3.66e-04 | 4 | 232 | 2 | C2931852 | |
| Disease | congenital heart disease (biomarker_via_orthology) | 3.66e-04 | 4 | 232 | 2 | DOID:1682 (biomarker_via_orthology) | |
| Disease | sleep duration, high density lipoprotein cholesterol measurement | 4.01e-04 | 121 | 232 | 6 | EFO_0004612, EFO_0005271 | |
| Disease | urate measurement, bone density | RIPOR3 TENM2 DHX35 UTRN MTHFD1L SYNE1 LAMA5 BCL11B PLXNA4 RBM6 ROBO1 CTNND2 ATP2B2 ATP2B4 | 4.25e-04 | 619 | 232 | 14 | EFO_0003923, EFO_0004531 |
| Disease | interleukin 17 measurement | 4.31e-04 | 45 | 232 | 4 | EFO_0008174 | |
| Disease | mental or behavioural disorder | 5.61e-04 | 179 | 232 | 7 | EFO_0000677 | |
| Disease | psoriasis, coronary artery disease | 6.06e-04 | 5 | 232 | 2 | EFO_0000676, EFO_0001645 | |
| Disease | lung carcinoma (implicated_via_orthology) | 6.06e-04 | 5 | 232 | 2 | DOID:3905 (implicated_via_orthology) | |
| Disease | Crohn's disease | EPHB4 KIF21B PSMA6 ADCY8 TYK2 TNFSF15 NOTCH2 DNMT3A HIF3A BCL11B DOCK7 | 7.95e-04 | 441 | 232 | 11 | EFO_0000384 |
| Disease | insomnia measurement | TANC2 PIK3C2A UBR5 RC3H2 VRK2 MON1B ASXL3 RBM6 CTNND2 ATP2B2 ATP2B4 | 8.25e-04 | 443 | 232 | 11 | EFO_0007876 |
| Disease | ICAM-1 measurement | 8.60e-04 | 24 | 232 | 3 | EFO_0004520 | |
| Disease | smoking status measurement | TENM2 ADCY8 FZR1 TGFBRAP1 HERC1 UTRN TET3 PLXNA2 VRK2 TCF20 NSF ST8SIA1 MON1B SDR9C7 BCL11B SETBP1 PLXNA4 CTNND2 PCCA CBX8 | 9.02e-04 | 1160 | 232 | 20 | EFO_0006527 |
| Disease | Hailey-Hailey disease (implicated_via_orthology) | 9.04e-04 | 6 | 232 | 2 | DOID:0050429 (implicated_via_orthology) | |
| Disease | level of Phosphatidylcholine (18:2_18:2) in blood serum | 9.04e-04 | 6 | 232 | 2 | OBA_2045106 | |
| Disease | free cholesterol to total lipids in very large HDL percentage | 9.28e-04 | 55 | 232 | 4 | EFO_0022288 | |
| Disease | Left ventricular mass to end-diastolic volume ratio | 9.71e-04 | 25 | 232 | 3 | EFO_0010556 | |
| Disease | systemic mastocytosis | 9.71e-04 | 25 | 232 | 3 | MONDO_0016586 | |
| Disease | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa | 1.08e-03 | 200 | 232 | 7 | EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351 | |
| Disease | body fat distribution | 1.14e-03 | 202 | 232 | 7 | EFO_0004341 | |
| Disease | disease of cellular proliferation (implicated_via_orthology) | 1.26e-03 | 7 | 232 | 2 | DOID:14566 (implicated_via_orthology) | |
| Disease | neuropilin-1 measurement | 1.26e-03 | 7 | 232 | 2 | EFO_0020603 | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 5 | 1.26e-03 | 7 | 232 | 2 | C0020075 | |
| Disease | smoking status measurement, Crohn's disease | 1.26e-03 | 7 | 232 | 2 | EFO_0000384, EFO_0006527 | |
| Disease | Dental enamel hypoplasia, dental caries, tooth agenesis | 1.26e-03 | 7 | 232 | 2 | EFO_0003819, EFO_0005410, EFO_1001304 | |
| Disease | triglycerides to total lipids in large HDL percentage | 1.29e-03 | 60 | 232 | 4 | EFO_0022330 | |
| Disease | cholesterol to total lipids in medium HDL percentage | 1.29e-03 | 60 | 232 | 4 | EFO_0022237 | |
| Disease | ganglion cell inner plexiform layer thickness measurement | 1.36e-03 | 28 | 232 | 3 | EFO_0600005 | |
| Disease | free cholesterol in HDL measurement | 1.37e-03 | 61 | 232 | 4 | EFO_0022264 | |
| Disease | HDL cholesterol change measurement, physical activity | 1.45e-03 | 62 | 232 | 4 | EFO_0003940, EFO_0007805 | |
| Disease | mammographic density percentage | 1.51e-03 | 29 | 232 | 3 | EFO_0006502 | |
| Disease | unipolar depression, bipolar disorder | 1.51e-03 | 156 | 232 | 6 | EFO_0003761, MONDO_0004985 | |
| Disease | Abnormality of the skeletal system | 1.67e-03 | 8 | 232 | 2 | C4021790 | |
| Disease | neural tube defect (is_implicated_in) | 1.67e-03 | 8 | 232 | 2 | DOID:0080074 (is_implicated_in) | |
| Disease | Alzheimer disease, survival time | 1.67e-03 | 8 | 232 | 2 | EFO_0000714, MONDO_0004975 | |
| Disease | NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO | 1.67e-03 | 8 | 232 | 2 | C3891448 | |
| Disease | epilepsy (implicated_via_orthology) | 1.89e-03 | 163 | 232 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | phosphatidylcholine measurement | 1.93e-03 | 284 | 232 | 8 | EFO_0010226 | |
| Disease | depressive symptom measurement | GALNT2 TENM2 HERC1 CACNA1E VRK2 TCF20 MON1B SDR9C7 ASXL3 ROBO1 | 2.13e-03 | 426 | 232 | 10 | EFO_0007006 |
| Disease | health-related quality of life measurement | 2.14e-03 | 9 | 232 | 2 | EFO_0011014 | |
| Disease | neural tube defect (implicated_via_orthology) | 2.14e-03 | 9 | 232 | 2 | DOID:0080074 (implicated_via_orthology) | |
| Disease | joint hypermobility measurement | 2.20e-03 | 33 | 232 | 3 | EFO_0007905 | |
| Disease | clopidogrel metabolite measurement | 2.20e-03 | 33 | 232 | 3 | EFO_0007966 | |
| Disease | facial emotion recognition measurement | 2.61e-03 | 35 | 232 | 3 | EFO_0008329 | |
| Disease | sugar consumption measurement | 2.64e-03 | 120 | 232 | 5 | EFO_0010158 | |
| Disease | phospholipids in large HDL measurement | 2.65e-03 | 73 | 232 | 4 | EFO_0022190 | |
| Disease | total lipids in large HDL | 2.79e-03 | 74 | 232 | 4 | EFO_0022189 | |
| Disease | cognition | 2.83e-03 | 36 | 232 | 3 | EFO_0003925 | |
| Disease | sexual dimorphism measurement | RALGAPA1 TTC39B IGF2-AS GALNT2 ADCY8 HERC1 GCN1 DNMT3A PITPNM2 USP49 COBLL1 POLR2A DUT FRYL NCOR2 LOXL1 EFR3B RBM6 | 3.01e-03 | 1106 | 232 | 18 | EFO_0021796 |
| Disease | inflammatory bowel disease | EPHB4 ZC3H13 ADCY8 TYK2 IFIH1 TNFSF15 PLXNA2 ST7 HIF3A BCL11B | 3.10e-03 | 449 | 232 | 10 | EFO_0003767 |
| Disease | Macrocephaly | 3.23e-03 | 11 | 232 | 2 | C0221355 | |
| Disease | MHPG measurement | 3.30e-03 | 38 | 232 | 3 | EFO_0005133 | |
| Disease | monounsaturated fatty acids; 16:1, 18:1 measurement | 3.37e-03 | 78 | 232 | 4 | EFO_0022187 | |
| Disease | physical activity measurement | 3.38e-03 | 245 | 232 | 7 | EFO_0008002 | |
| Disease | free cholesterol in large HDL measurement | 3.53e-03 | 79 | 232 | 4 | EFO_0022157 | |
| Disease | corpus callosum anterior volume measurement | 3.56e-03 | 39 | 232 | 3 | EFO_0010295 | |
| Disease | free cholesterol measurement, high density lipoprotein cholesterol measurement | 3.63e-03 | 315 | 232 | 8 | EFO_0004612, EFO_0008591 | |
| Disease | cholesterol in large HDL measurement | 3.69e-03 | 80 | 232 | 4 | EFO_0021900 | |
| Disease | airway wall thickness measurement | 3.86e-03 | 12 | 232 | 2 | EFO_0006898 | |
| Disease | Charcot-Marie-Tooth disease | 4.39e-03 | 42 | 232 | 3 | cv:C0007959 | |
| Disease | level of Phosphatidylinositol (18:1_18:1) in blood serum | 4.53e-03 | 13 | 232 | 2 | OBA_2045159 | |
| Disease | triglycerides in large LDL measurement | 4.70e-03 | 43 | 232 | 3 | EFO_0022319 | |
| Disease | lipid measurement, high density lipoprotein cholesterol measurement | 4.79e-03 | 330 | 232 | 8 | EFO_0004529, EFO_0004612 | |
| Disease | Profound Mental Retardation | 4.93e-03 | 139 | 232 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 4.93e-03 | 139 | 232 | 5 | C0025363 | |
| Disease | Mental deficiency | 4.93e-03 | 139 | 232 | 5 | C0917816 | |
| Disease | Malignant neoplasm of breast | EPHB4 BOC APC2 SORCS1 SLC2A10 NOTCH2 DNMT1 DNMT3A TCP1 SYNE1 EDNRA SIPA1L1 SETBP1 TENM1 ROBO1 LONRF3 TP73 | 5.13e-03 | 1074 | 232 | 17 | C0006142 |
| Disease | ulcerative colitis | 5.24e-03 | 335 | 232 | 8 | EFO_0000729 | |
| Disease | QRS complex, QRS duration | 5.34e-03 | 45 | 232 | 3 | EFO_0005054, EFO_0005055 | |
| Disease | cancer (implicated_via_orthology) | 5.49e-03 | 268 | 232 | 7 | DOID:162 (implicated_via_orthology) | |
| Disease | carbohydrate measurement | 5.68e-03 | 46 | 232 | 3 | EFO_0004998 | |
| Disease | response to hydrochlorothiazide, triglyceride measurement | 6.03e-03 | 47 | 232 | 3 | EFO_0004530, EFO_0005202 | |
| Disease | Primary biliary cirrhosis | 6.03e-03 | 47 | 232 | 3 | C0008312 | |
| Disease | anemia (implicated_via_orthology) | 6.04e-03 | 15 | 232 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | YKL40 measurement | 6.04e-03 | 15 | 232 | 2 | EFO_0004869 | |
| Disease | lobe attachment | 6.08e-03 | 207 | 232 | 6 | EFO_0007667 | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 6.18e-03 | 274 | 232 | 7 | EFO_0004530, EFO_0004612 | |
| Disease | Neurodevelopmental Disorders | 6.30e-03 | 93 | 232 | 4 | C1535926 | |
| Disease | frontal fibrosing alopecia | 6.40e-03 | 48 | 232 | 3 | EFO_0009855 | |
| Disease | Alzheimer disease, dementia, family history of Alzheimer’s disease | 6.40e-03 | 48 | 232 | 3 | EFO_0009268, MONDO_0001627, MONDO_0004975 | |
| Disease | acute myeloid leukemia (is_marker_for) | 6.77e-03 | 49 | 232 | 3 | DOID:9119 (is_marker_for) | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 6.77e-03 | 49 | 232 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | body mass index, type 2 diabetes mellitus | 6.87e-03 | 16 | 232 | 2 | EFO_0004340, MONDO_0005148 | |
| Disease | mammographic density measurement | 7.16e-03 | 50 | 232 | 3 | EFO_0005941 | |
| Disease | polyunsaturated fatty acids to total fatty acids percentage | 7.16e-03 | 50 | 232 | 3 | EFO_0022303 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 7.35e-03 | 153 | 232 | 5 | EFO_0004611, EFO_0020946 | |
| Disease | low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 7.35e-03 | 153 | 232 | 5 | EFO_0004611, EFO_0020944 | |
| Disease | HbA1c measurement | ATXN7L3 FZR1 AEBP1 NFKBIL1 NOTCH2 ARAP1 NSF COBLL1 TFR2 MACO1 TET1 ATP2B4 | 7.50e-03 | 675 | 232 | 12 | EFO_0004541 |
| Disease | apolipoprotein A 1 measurement | TTC39B GALNT2 CXXC1 FZR1 RIPOR1 HERC1 DOCK6 PITPNM2 COBLL1 NCOR2 DOCK7 RBM6 VPS53 RCN3 | 7.55e-03 | 848 | 232 | 14 | EFO_0004614 |
| Disease | polyunsaturated fatty acids to monounsaturated fatty acids ratio | 7.57e-03 | 51 | 232 | 3 | EFO_0022302 | |
| Disease | body fat percentage, type 2 diabetes mellitus | 7.74e-03 | 17 | 232 | 2 | EFO_0007800, MONDO_0005148 | |
| Disease | Charcot-Marie-Tooth disease type 2 | 7.74e-03 | 17 | 232 | 2 | cv:C0270914 | |
| Disease | triglyceride measurement, alcohol drinking | 7.83e-03 | 99 | 232 | 4 | EFO_0004329, EFO_0004530 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ATGQSRAMIAAAARR | 321 | Q8TAA9 | |
| RGMTSECSEIRQAGR | 156 | O95150 | |
| QHRMLSRASGVTGRR | 381 | A9YTQ3 | |
| NLASRMDSTGVSGRI | 1116 | P40145 | |
| RSMNGSRRNSGSSLV | 56 | Q96CN4 | |
| MAGQRTCQRRSSRAG | 1 | Q96M60 | |
| EQDSVERRMGTAVGR | 936 | Q8WVB6 | |
| QERRRIGSMTGAEQA | 236 | P04920 | |
| SVRDQDREGAGRMRV | 136 | O75638 | |
| LRRTNSLMVSRGSGL | 981 | Q15878 | |
| NQARSEARRVGMADA | 111 | P26358 | |
| DVSNMSRLARQRLLG | 876 | Q9Y6K1 | |
| EIRRGTSAASRMITN | 131 | Q8N9M1 | |
| LITTQRDTAMSQRGR | 386 | O94812 | |
| RDTAMSQRGRSGFLS | 391 | O94812 | |
| AQMRLRRLNATTTLG | 1031 | Q8IUX7 | |
| GEATATDQTMDGRRR | 1616 | Q7Z2Y8 | |
| RESRERAQSLSMGTR | 466 | Q9UDR5 | |
| RGITDQGTMNRLLTS | 291 | Q8IU99 | |
| EMLNRRNGSLRIALS | 281 | P25101 | |
| EQAERLGMGLVSRSS | 301 | Q8N6H7 | |
| GASGEDALSRIQRLM | 1141 | Q9C0C7 | |
| STLMTNGADTARRGI | 356 | Q8NB46 | |
| GSVGRRSRLAQDFMA | 491 | Q9Y4F5 | |
| MASATAAAARRGLGR | 1 | Q96HY7 | |
| LSAMRNLNGREFSGR | 71 | P33240 | |
| LAAALRIQNMVSSGR | 321 | Q6UB35 | |
| EAGRVRAGSLQLSSM | 336 | Q53SF7 | |
| MRQSLLTAIRSGEAA | 1081 | Q53SF7 | |
| NVSSAGEEARRRMRE | 721 | Q9UQB3 | |
| TVRMVTGDNINTARA | 726 | Q01814 | |
| TVRMVTGDNINTARA | 691 | P23634 | |
| LGMGRNSSRIANRRI | 106 | Q14CW9 | |
| DRQMGSDGILRLSTS | 291 | Q9C0F0 | |
| STQEMEARLAALQGR | 216 | Q96K21 | |
| RLLGTSQMSSDARGL | 371 | Q149M9 | |
| EGRVRAMRAARSLGE | 146 | Q9HBD1 | |
| AMRAARSLGERTVTE | 151 | Q9HBD1 | |
| SQARLGRIVDRMDRA | 76 | Q96D15 | |
| RGRGLLRLNDMASTD | 421 | Q9H6Z4 | |
| DGTLQSRLVMRTQGS | 436 | Q9H6Z4 | |
| RRQLCGGSQAAIERM | 606 | Q96S59 | |
| SRTSVMDRQARRLGG | 181 | Q8IZ40 | |
| ASTQGRRMDDQRVTV | 71 | Q8IVA1 | |
| ARRGNDAVMTRGTFA | 786 | P48200 | |
| SMGLQERRGSNVSLT | 236 | P54829 | |
| GARARAMQRASTIDV | 11 | Q96PE3 | |
| HRDGQRSSIMDVRSR | 391 | Q969V3 | |
| MSRTSQSAAQLRGEL | 176 | Q7L1V2 | |
| EMAQNGSSRILTLRG | 1406 | O75147 | |
| RMAQTQRTRTSRGSD | 906 | Q99102 | |
| GRRKGRITRSMANEA | 576 | Q9Y618 | |
| RNRVTDLDARMNDGT | 1931 | Q04721 | |
| GAGGQNMRDRATIRR | 26 | Q13823 | |
| EVRLFLRGGTSDQRM | 61 | Q8TD91 | |
| LRGGTSDQRMDSLVL | 66 | Q8TD91 | |
| SLGRALMRHQTQRSR | 11 | Q9H089 | |
| MQEAKGRGSAAARSR | 266 | Q9HB89 | |
| RSAAQRAMQAEDGRL | 496 | Q7RTR2 | |
| RQRREFLSEASIMGQ | 656 | P54760 | |
| LRMLASQASAGRRLS | 1481 | Q8N201 | |
| FGRRKSRQGSLAMEE | 346 | P16150 | |
| RGSMLGLAASFSRRN | 51 | Q5JR98 | |
| LFRARDNMRGRTTVG | 221 | O95528 | |
| SRRTRAEMGGLTAQA | 261 | Q9NYG8 | |
| EGALSMARATLAQRS | 356 | Q9HB07 | |
| LTSRSAAQDLDRMGV | 651 | O75335 | |
| MRRGLNSRLEATAAS | 126 | Q9NQW6 | |
| FTTMSGRRLREAVQA | 541 | Q9NR71 | |
| SMRSTLDRLQSERGR | 201 | Q5XKE5 | |
| VGSNRDREISMSVGL | 4441 | Q2LD37 | |
| DREISMSVGLGRSQL | 4446 | Q2LD37 | |
| REGLMRSRVRGADAA | 201 | Q10471 | |
| ARSRDRDRMNSGAGS | 1396 | Q15751 | |
| RARSSGIMSQVGREE | 1466 | Q9BY66 | |
| QAACRARGMRALGVT | 376 | O95202 | |
| STGMARARTSVSQQR | 136 | Q08397 | |
| TRGLRNATQRMFEID | 21 | P16278 | |
| AGMAAVVDRIRENRG | 836 | P52789 | |
| STERGIRSEMGQLRQ | 416 | Q8N5G2 | |
| ASMARGGVSARVLLQ | 6 | Q6P4F2 | |
| TLELQRSFSMRDRGN | 1371 | O75051 | |
| RSFSMRDRGNVASLI | 1376 | O75051 | |
| TLESQRSFSMRDRGN | 1371 | Q9HCM2 | |
| RSFSMRDRGNVASLI | 1376 | Q9HCM2 | |
| ASGSARQVVLQRSME | 1066 | O00443 | |
| STQQRRREMAAASAA | 6 | Q14807 | |
| LEGGSQLALRRATSM | 991 | Q92614 | |
| GARRRGERVSMAEET | 246 | P43116 | |
| RRAAVSRLGNMSQID | 786 | Q8IVL0 | |
| MASRLLRGAGTLAAQ | 1 | P10606 | |
| TGRTGENRNRLTQIM | 416 | Q9Y2G0 | |
| ASAGQQRSRMLATLF | 236 | Q9BT78 | |
| RGDRRRSNTLDIMDG | 1951 | O94915 | |
| RLLEGRLRQTDMAGS | 1056 | O75037 | |
| MRGQGRKESLSDSRD | 1 | Q9NS61 | |
| MTRGARLRSDARAQL | 1 | Q7L591 | |
| LEGLVRAAQSTAMNR | 441 | P46459 | |
| VSRNMTRSRREGDTG | 226 | Q96CW5 | |
| MGRSDTQLVVRQASL | 1891 | Q92616 | |
| IASVRRRDLANMTGL | 71 | Q9BTN0 | |
| AVRARGLLDRSFANM | 551 | Q32M88 | |
| NRGAMSVSGRVSVRE | 936 | O15230 | |
| RVMGAVTALSQALNR | 361 | Q9UBC1 | |
| ETRRAMGEQAVALAR | 311 | P05165 | |
| RRGSVVSMQDNDLLS | 586 | Q9BZ72 | |
| RRASEISIASQVSGM | 831 | Q9BZ72 | |
| ESIRSERGNSRMNSA | 221 | Q13316 | |
| TSLLRSAMQNARGAR | 16 | P33316 | |
| GGDLTRDSRVMLRQV | 321 | Q9Y6X9 | |
| MAENSQGSILSRARL | 396 | Q2VWP7 | |
| TLEMRDGQVLGRRSF | 276 | O15350 | |
| ERILNSVGSRMGSTD | 481 | Q16322 | |
| AEQLSSGSRDRMILQ | 281 | Q9UM11 | |
| QGSRRMSAAEQGSLR | 626 | A4FU69 | |
| TSAQRRGEISRMREV | 201 | O00471 | |
| RFGTSDEMVQRAQIR | 201 | O95996 | |
| NVRTAMTNRAGLLAL | 621 | Q9P0U4 | |
| MRAESRSGAQRRRGS | 51 | Q6U949 | |
| MRSARSTALNRGEQR | 1 | Q8N954 | |
| MDFSRRLRELAGNSS | 361 | Q9C0K0 | |
| GEGQTAMVTFRTGRR | 556 | Q9BWV1 | |
| STSRAREGLRNMGLS | 116 | Q9HC52 | |
| LGTIGARQEMVRRSR | 1326 | Q96HP0 | |
| LGSIGARQEMVRRSR | 1401 | Q96N67 | |
| ARQEMVRRSRGQLGT | 1406 | Q96N67 | |
| ARGRVVNMSSSGGRV | 151 | Q8NEX9 | |
| SDTGRTLMRGLARNV | 1926 | Q99715 | |
| GRRITTRRIMENGQE | 176 | P25686 | |
| VSMLIEQARALARTG | 291 | Q9H5Z1 | |
| RQRRDFLSEASIMGQ | 676 | P29322 | |
| MTRLDQLRAESASGN | 186 | Q02318 | |
| LMDAIRSGTGAARLR | 1241 | O75128 | |
| DGEVRAASERLNRMS | 281 | Q9NQT6 | |
| TNEIAMVQARGRARA | 811 | Q9BYX4 | |
| SVTRGEREQRDMLGS | 91 | Q9H3Q1 | |
| NEISMVQARGRARAD | 461 | Q96C10 | |
| AANASELAALRMRVG | 56 | Q8NI99 | |
| DRLRTMTNVLGDSIG | 501 | P48664 | |
| GRTARATNEGLSLML | 676 | Q9GZR7 | |
| RQNISRTVMQRGSLG | 76 | Q8N7U6 | |
| QANARLAKRGGRTMA | 3156 | Q14204 | |
| MAASVRQARSLLGVA | 1 | Q8TAE8 | |
| RILQDSLGGNCRTTM | 286 | Q12840 | |
| RLSGAAVSTRGRFMT | 131 | Q7Z7F0 | |
| SIASMQERRSTLGAA | 376 | Q9UH77 | |
| EAQDTMQGTSRSLRL | 996 | Q13751 | |
| LSAMRNLNGREFSGR | 71 | Q9H0L4 | |
| SRFLRMEAVRSTAGL | 361 | Q5T1A1 | |
| SSRDDRGRVRMAGAL | 131 | Q9Y6H8 | |
| RGREGRTMTSRASEL | 91 | Q8NFF5 | |
| MLRVSSGGRNSSETR | 866 | Q8TDX9 | |
| RGSGVFRLTVRNAMA | 16 | Q8IZK6 | |
| SSASREIGRAMRFIS | 1836 | A6NMZ7 | |
| RSGRDDAIQNFMRST | 2231 | A6NMZ7 | |
| LSGAQRALMRRAGCS | 126 | A0A1W2PPM1 | |
| GRDARARRAQTAAMA | 36 | Q86X29 | |
| ELSRMGVSEASTGQR | 336 | Q9BZF2 | |
| MSELLRARSQSSERG | 1 | Q7Z2X7 | |
| RVNLSSADAGRQTMR | 431 | Q13835 | |
| ALILMNARGSSSREL | 1711 | P46939 | |
| HRSRTDQDFRGREMG | 261 | P78332 | |
| ERQVGRAAAALMQDR | 361 | Q13671 | |
| GIRQALSRARAMLSA | 401 | Q13671 | |
| RQTDHRMAGQSERRA | 176 | Q96M34 | |
| RRMSGEAERRTSEQI | 196 | Q96M34 | |
| SIMSRNNADTGRVLA | 31 | Q8IUE1 | |
| SIMSRNNADTGRVLA | 31 | Q8IUE0 | |
| ASLELRSQRMSRDSG | 5076 | Q8NF91 | |
| RSQRMSRDSGAQVDL | 5081 | Q8NF91 | |
| VSSVRERVGRMQQAT | 146 | Q8IW70 | |
| DGRDGVDNRSMRRSL | 1241 | O14513 | |
| MGVANARNASLERAR | 1416 | Q9Y2K3 | |
| VTAGAMQRLRARGLT | 146 | P78549 | |
| DMLRAFGTSRQARGL | 966 | O14841 | |
| MALGLQRARSTTELR | 1 | Q9Y2N7 | |
| MAAESGSDFQQRRRR | 1 | Q96BP3 | |
| GRSVLRDQALAMSTL | 16 | A6NGN4 | |
| QRVGAGRRSREMALL | 306 | Q9H0A6 | |
| MRRFRSQNGSLGSSV | 36 | O43166 | |
| RARRQTSRGAMAVLA | 6 | Q92185 | |
| RVMGSGSALSRNDVL | 426 | Q9UHJ6 | |
| RSTGETIRSQNVMAA | 11 | P17987 | |
| SMGGARTQQDLRVRF | 301 | Q9HCD6 | |
| SQMTSVLNGRTRRFA | 2606 | Q9UKZ4 | |
| LAGLQRGAMSERTDI | 1901 | Q9NT68 | |
| SIRMGDIRRGVNQAL | 821 | Q8NEZ3 | |
| LGTRMEQEGSRALTS | 666 | Q9NQW1 | |
| AQMVLSRSQEGRGTR | 1516 | Q14160 | |
| NLETAMSVIGDRRSR | 51 | Q9NX55 | |
| GSTRVEQRQALMERF | 2091 | Q6ZRS2 | |
| SRRGLSTAEMNAVEA | 391 | Q9NRC1 | |
| RSLLTRAGAARMNLD | 71 | Q8NFU7 | |
| LAGREMTRLAGFTAR | 376 | P28288 | |
| QAMAEQRARARLSSA | 416 | Q96P48 | |
| RGSENEMRRSVAAFT | 1426 | Q96P48 | |
| SRRGVMASSLQELIS | 46 | O60543 | |
| VRSNLMVATGDLAIR | 1071 | Q15021 | |
| VGRRRQMRASNVSSD | 86 | Q96N96 | |
| RGSSRRGSMNNELLS | 586 | O00562 | |
| TGMTADSRSQVQRAR | 81 | P60900 | |
| RSQEMGGAERALVAR | 1401 | O15417 | |
| RTDSRRGMQRSAQLS | 191 | P52198 | |
| RRTMQVALGLARSEN | 781 | Q8WUH2 | |
| RIAQRGRNTSRMAED | 26 | Q8TC36 | |
| RGVSSQRASSVNEMR | 156 | P0CG00 | |
| SSQRRNMALLGSRAE | 61 | Q5VTQ0 | |
| LLQLREGASGRSMRS | 336 | Q5VTQ0 | |
| RLRSGNASTMTRRGS | 846 | Q6GYQ0 | |
| SLLRSAAGRTMSQGR | 6 | Q9BQ52 | |
| GETGVRRRTQAMSRS | 671 | Q13009 | |
| RRVLANALASMGVSL | 136 | O15375 | |
| RLRDGASSMQRAFAR | 151 | Q96MK2 | |
| RRMGRASALTAASGE | 341 | Q8IWN7 | |
| QGQRRHRSRASAMSS | 636 | Q8IWN7 | |
| RGLSDRVNMRTSSSI | 1926 | Q9Y5Y9 | |
| RNATVEMTRRHIGRG | 321 | Q15796 | |
| DGRQQVGSSRLRHIM | 796 | Q96PX9 | |
| RVRAVVMTRDDSSGG | 16 | Q7Z699 | |
| SGDQSAAQRRSQMDR | 11 | Q9NVW2 | |
| SVSNRNMERAESRSG | 431 | Q9NVW2 | |
| RGNLMGKRVDFSART | 351 | P24928 | |
| LMNQGRTEEARRTFL | 571 | Q8N394 | |
| VRRGRTLRSMASGED | 111 | Q70CQ1 | |
| MASEQDVRARLQRAG | 1 | Q3KQV9 | |
| HMRDAQGRLDSTRGL | 111 | P53007 | |
| VSSIMGNGRRRSISC | 1146 | Q9P273 | |
| SEQRMGISIQGSRVS | 1681 | Q68DE3 | |
| ARDRLMSEVLTGRQQ | 371 | Q9BT92 | |
| SMSSRGSGSRQREQA | 1606 | Q9Y6N7 | |
| GHMSADTRIGRNDRL | 886 | Q9UGU0 | |
| REMSREAGNNSRGPR | 226 | O43151 | |
| TEMLRSRALNLGAAT | 101 | Q6ZWC4 | |
| RVNLRVSGREASREM | 31 | Q6ZVQ6 | |
| AGGVDSLEAMTRRRQ | 156 | Q5VIR6 | |
| MAASAARGAAALRRS | 1 | Q9GZT3 | |
| RMRGRLGSVDSFERS | 581 | O60343 | |
| SREGRTRDRQMAAAL | 101 | O95201 | |
| AGRRTLQGRAKMASV | 26 | Q9UPP1 | |
| AGSIMREGRDRVVNL | 271 | Q9UNX4 | |
| RARGTGASMAVAARS | 91 | Q8WY21 | |
| GERGRLQTSQLQRMA | 286 | A5PLN9 | |
| ESLLMQRQGLTRSRA | 826 | Q6ZS17 | |
| MESRETLSSSRQRGG | 1 | Q9Y6X0 | |
| GMAALTQDIRAALSR | 171 | Q9UP52 | |
| DSNRQVTMRRISGLR | 121 | Q9NWH7 | |
| GQGRQETLFRCIRSM | 186 | O75888 | |
| GLMNNEAAQESTRRR | 386 | Q86Y07 | |
| EMRLRRFQSVESGAN | 111 | Q9NXG2 | |
| SRSEIRNDRMGRSRG | 551 | Q5T200 | |
| MASIIARVGNSRRLN | 1 | Q6PEW1 | |
| EGRRRATLLSARQGM | 1896 | O95071 | |
| MPASQSRARARDRNN | 1 | Q8NBV4 | |
| REVAMSTRDRFQLTG | 81 | A6NMB1 | |
| GETSNLIIMRGARAS | 556 | P29597 | |
| SAALRMLGSRALAQQ | 921 | Q5TIE3 | |
| TSVANMRDRRSTLGA | 381 | O95198 | |
| MRDRRSTLGAAVLNG | 386 | O95198 | |
| ALMVATGRARGARRA | 201 | Q496Y0 | |
| ALRTERRDQAVMISG | 126 | O00159 | |
| QATRLMTGAGNVLRR | 356 | Q9UPR5 | |
| LAASQRAMLAGSARR | 66 | Q8TDC0 |